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Abstract: Klebsiella pneumoniae is a Gram-negative pathogen associated with numerous 
infections. Like all Gram-negative bacteria, K. pneumoniae naturally release outer membrane 
vesicles (OMVs) during all stages of cellular growth. OMVs are composed of the outer 
membrane components such as lipopolysaccharide (LPS) and outer membrane proteins and 
contain cytosolic and periplasmic proteins in the lumen. K. pneumoniae is often found to lack an 
O antigen. The absence of the O antigen has been reported to alter the protein content of the 
membrane which may further alter the immune response elicited by K. pneumoniae. Therefore 
the purpose of this study was to analyze the protein content and inflammatory responses of the 
cellular outer membrane (OM) and the secreted OMVs. A secondary goal of this study was to 
evaluate any changes to the membrane protein content due to O antigen loss and determine if the 
loss of the O antigen influences the inflammatory response. This study demonstrated that the 
cellular OM and OMVs have distinct protein profiles as well as inflammatory responses. OMVs 
were highly enriched in outer membrane proteins compared to the cellular OM and had a 
significantly stronger inflammatory response. The protein content of the OM and OMVs were 
further modified by the absence of the O antigen from the outer membrane. Although there were 
no significant differences seen in the wild type and O antigen deficient OM inflammatory 
























 Klebsiella pneumoniae is a nosocomial pathogen associated with numerous infections 
ranging from mild urinary tract infections to bacteremia, pneumonia, and pyogenic liver abscess 
(1-3). This pathogen has become resistant to many late generation antibiotics and hospital 
acquired K. pneumoniae infections have a 50% mortality rate if left untreated (2, 4). Although K. 
pneumoniae is a prominent nosocomial, multi-drug resistant pathogen, there is a general lack of 
knowledge with regards to the pathogenesis of and immune response to K. pneumoniae.  
 K. pneumoniae has several virulence factors including an anti-phagocytic capsular 
polysaccharide (CPS), lipopolysaccharide (LPS), and adhesins (5). LPS is important for the 
maintenance and integrity of the outer membrane and contains molecular structures that serve as 
recognition molecules for the immune system. It is considered the most potent stimulator of the 
innate immune response to Gram-negative, enteric bacteria such as Klebsiella pneumoniae  (6). 
The LPS is a three part structure consisting of the lipid A, core oligosaccharides, and the O 
antigen (Figure 1.1) (7). The lipid A is integrated into the bacterial outer membrane and has a 
structure that is conserved among Gram-negative, enteric bacteria (6). The lipid A is the 
pathogen associated molecular pattern (PAMP) for toll-like receptor 4 (TLR-4) on the surface of 














Figure 1.1 General structure of the Lipopolysaccharide (LPS) of 




Graphic redacted, paper copy available upon request to 
home institution.
 The O antigen consists of several (up to fifty) repeating carbohydrate subunits linked to 
the core polysaccharide of the LPS molecule (8, 10).  Each repeating unit is composed of up to 
eight hexose sugars that differ based upon sugar, sequence, linkage, and ring forms (8). The O 
antigen is variable between and within Gram-negative species. Because the O antigen is the outer 
most portion of the bacterial cell structure, it is recognized and targeted by the host’s adaptive 
immune response. This non-protein antigen stabilizes the bacterial cell wall, helps regulate 
permeability, and protects the bacterial cell by physically hiding other outer membrane 
components from antibodies and complement proteins (11). 
 Although the O antigen has stabilizing properties, the O antigen can be truncated or 
absent in Gram-negative bacteria (6). For example, Escherichia coli and Salmonella 
thyphimurium, can exhibit mutations in the genes responsible for the synthesis and attachment of 
the O antigen and produce rough LPS mutants lacking their O antigens (12). A serotype analysis 
of over 600 K. pneumoniae clinical isolates obtained from the United States, Denmark, and 
Spain determined that roughly 14% of the isolates completely lacked the O antigen from their 
cell surface (11, 13).   K. pneumoniae is only one of several Gram-negative pathogens in which 
O antigen loss has been identified. Cystic fibrosis patients have been observed with O antigen-
deficient strains of Pseudomonas aeruginosa (14). Yersinia pestis, the causative agent of the 
plague, is an exclusively O antigen-deficient bacterium (15). Other pathogens, such as strains of 
Acinetobacter baumannii and Neisseria meningitis, have been isolated lacking LPS entirely (16, 
17). Even though A. baumannii and N. meningitis lack the entirety of the LPS molecule, these 
pathogens are still capable of stimulating a potent inflammatory response in vitro. 
 It has been established that K. pneumoniae, among other Gram-negative bacteria, 
naturally secrete LPS and other cell derived components through the production of outer 
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membrane vesicles (OMVs) (18). OMVs are 20-200nm spherical bilayers released from the 
outer membrane of Gram-negative bacteria during all phases of growth (Figure 1.2) (19). OMVs 
can serve as decoys that aide in bacterial survival by releasing toxic compound from the cells. 
OMVs remove over-expressed or mis-folded proteins to relieve bacterial envelope turgor 
pressure, and OMVs can also release attacking phages and antimicrobial peptides that bind to the 
membrane (20). OMVs are involved in cell-to-cell communication and have been known to be 
involved in the transfer of antibiotic resistance enzymes and horizontal gene transfer between 
bacterial species (21, 22).  
 OMVs form when part of the outer membrane protrudes and is released from the cell. 
Therefore the contents of the OMVs are reflective of the outer membrane containing LPS, 
phospholipids, and outer membrane proteins with cytosolic and periplasmic proteins trapped in 
the vesicle lumen (Figure 1.2) (18, 23, 24). Although the OMVs are derived from the cellular 
outer membrane, the protein content of OMVs are distinct from the outer membrane. This has 
been confirmed by visualization of the protein content of the cellular outer membrane and 
secreted OMVS indicate that OMVs have protein profiles that are dissimilar to those of the outer 
membrane (25-27). The enrichment or exclusion of protein cargo into OMVs has been well 
demonstrated by many pathogenic bacteria that selectively package virulence factors into OMVs 
(26, 28). For example, Enterotoxigenic Escherichia coli (ETEC) exclusively packages heat labile 
enterotoxin into OMVs (16). In the dental pathogen Porphorymonas gingivalis, ninety five 
percent of the gingipain protease produced by this pathogen becomes packaged into OMVs (28). 
These studies indicate that a selective sorting mechanism may exist for inclusion of protein cargo 
into OMVs; however, the current OMV proteomic studies are limited to only evaluating the 
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protein content of the OMVs and lack a comprehensive proteomic analysis comparing the OMV 


























Figure 1.2 Outer membrane vesicles (OMVs) are released from the 
outer membrane of Gram-negative bacteria. OMVs contain outer 
membrane components such as lipopolysaccharide, phospholipid, and 
outer membrane proteins. Cytosolic and periplasmic proteins are 
integrated into the lumen of OMVs during vesicle formation. Kuehn 
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 The protein content of OMVs is not only distinct from the outer membrane but can be 
altered by other changes to the outer membrane, such as O antigen loss. It has been established 
that the absence of the O antigen drastically impacts the protein content of OMVs.  P. gingivalis 
strains that lacked the O antigen produced OMVs that carried additional protein and virulence 
factors that were absent from the source bacterial cell (26). The loss of the O antigen also altered 
the protein content of OMVs derived from P. aeruginosa (25). It has been proposed in several 
reviews addressing the formation of cargo selection of OMVs that charged O antigen sugar 
residues may directly interact with certain protein microdomains causing these proteins to be 
packaged into OMVs (26, 29).    
 Furthermore, modifications to the outer membrane and OMVs resulting from O antigen 
loss may also alter their inflammatory response. The LPS is the key immunogen of Gram-
negative bacteria and vesiculation is the main LPS delivery mechanism that Gram-negative 
pathogens employ during an infection. OMVs are enriched in lipopolysaccharide (LPS) and 
outer membrane proteins that synergistically stimulate the host immune response (18, 30, 31). K. 
pneumoniae- and P. aeruginosa-derived OMVs stimulate a potent inflammatory response (30, 
31). It has also been demonstrated that rough and smooth LPS elicit different immune responses 
in vitro and in vivo (32-35). However, the previously described studies used chemically extracted 
LPS and it has been shown that vesicle bound LPS and protein cargo produced a significantly 
stronger inflammatory response when compared to purified LPS (31). Therefore, OMVs should 
be included when evaluating LPS-related immunological studies.  
 O antigen loss has been identified in K. pneumoniae clinical isolates, therefore, analyzing 
how O antigen loss influences the ability of OMVs to stimulate the immune response should be 
considered when studying the pathogenicity of K. pneumoniae, since these factors occur 
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simultaneously during infection. The study performed by Evrard et al. (2010), noted that K. 
pneumoniae strains with LPS mutations were capable of up-regulating cytokine production in 
dendritic cells (2). However this study only analyzed the effects of O antigen loss on the immune 
response to K. pneumoniae cells and did not include OMVs in their analysis. OMVs are being 
studied as possible candidates for acellular vaccines and targets for antibody treatments (18, 30, 
31). A recent study by Leitner et al. (2013), analyzing possible Vibrio cholerae OMV vaccines 
stated that mice inoculated with OMVs derived from an O antigen-deficient strain of V. cholerae 
were able to produce a more specific, protective immune response than mice inoculated with 
wild-type vesicles (36). V. cholerae OMVs lacking the O antigen were enriched in proteins that 
were absent from wild-type OMVs. Because these V. cholerae OMVs lacked their O antigens 
and the outer membrane surface antigens were exposed, O antigen-deficient V. cholera OMVs 
produced a stronger immune response than wild-type OMVs (36). 
 In K. pneumoniae, O antigen loss and OMVs have been studied independently of one 
another. The protein content of the outer membrane is distinct from the OMV content. Studies 
conducted by Haurat et al. (2011) and Murphy et al. (2014), demonstrated that O antigen loss 
drastically alters OMV protein content (25, 26). The changes to the membrane and the secreted 
vesicles produced by the absence of the O antigen could also drastically alter the inflammatory 
response to K. pneumoniae. As seen in the results obtained in the V. cholerae OMV vaccine 
study, both O antigen loss and OMV should be evaluated together when analyzing the immune 
response to K. pneumoniae. Therefore, a comprehensive proteomics-based study was designed to 
evaluate the differences between the outer membrane and OMV sub-proteomes. This proteomic 
analysis also analyzed the impact of O antigen loss of the both the membrane and secreted 
OMVs. The second part of this study focused on how the resulting changes influenced the 
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inflammatory responses to the cellular outer membrane and OMVs. Specifically, this study 
addressed whether the inflammatory response differed between the cellular and secreted outer 
membrane components and whether the loss of the O antigen further altered either of their 
inflammatory responses.  It is anticipated that the protein content of the outer membrane and 
OMVs will be distinct from one another and therefore potency of the inflammatory response will 
vary between these different membrane components. It is also anticipated that  both the protein 
content and the inflammatory response of the membrane and OMVs will be further altered by the 















Proteomic Analysis of the Cellular Outer Membrane and Secreted Outer Membrane Vesicles in 


















 Gram-negative bacteria naturally secrete lipopolysaccharide (LPS) and other cell derived 
components through the production of outer membrane vesicles (OMVs) (18, 30). OMVs are 20-
200nm diameter spherical bilayers released from the outer membrane of Gram-negative bacteria 
during all phases of growth (19).  Outer membrane vesicles may be used as a method of secretion 
and delivery for a variety of bacterial virulence factors, including invasion-associated factors, 
antibiotic resistance enzymes such as β-lacatamase, toxins, and components that modulate host 
immune responses (23, 28, 29). In fact, some of these proteins, such as the heat labile enterotoxin 
of enterotoxigenic Escherichia coli (ETEC), and the gingipain proteases in Porphorymonas 
gingivalis, are delivered to host cells nearly exclusively by OMVs (26, 28). This selective 
packaging of cargo into OMVs allows these extracellular structures to function as virulence 
factors separate from the bacterial cell. 
 The proteomic profile of OMVs have been evaluated for a number of Gram-negative 




(37). Most of these studies have focused on the contents of purified vesicles without a side-by-
side comparison to the source bacterial outer membrane. These experiments have confirmed that 
OMVs are enriched in outer membrane and periplasmic proteins, while they also contain 
cytoplasmic proteins suggesting that a selective mechanism exists to package proteins into 
OMVs. With the exception of N. meningitidis and N. gonorrhoeae, most proteomic-based OMV 
analyses have not directly analyzed or compared the protein content of OMVs to the outer 
membrane of the originating cells (27, 38, 39). In this study, we aimed to analyze how the OMV 
sub-proteome compares to that of the outer membrane and to identify the key protein 
components that are selectively packaged from the outer membrane into the OMV sub-proteome.  
 For this study we focused on the membrane and vesicles from Klebsiella pneumoniae, a 
nosocomial pathogen associated with numerous infections such as urinary tract infections, 
bacteremia, pneumonia, pyogenic liver abscess, and ankylosing spondylitis (1-3, 40). Hospital 
acquired K. pneumoniae infections have a 50% mortality rate if left untreated, in large part due to 
the rapid acquisition of antibiotic resistance, adding to the challenge of treatment of this infection 
(2, 4). Given this high level of clinical significance, there is scant knowledge of virulence 
mechanisms for this organism other than the capsule. There has been only one published study to 
date analyzing the pathogenicity and protein composition of K. pneumoniae OMVs (30); which 
used a limited dataset of 159 proteins to focus primarily on the ability of K. pneumoniae OMVs 
to elicit an inflammatory response (30). Therefore, basic knowledge of the protein components 
most enriched in OMVs from this clinically significant species remains uncharacterized. 
 Beyond the protein components, both the bacterial outer membrane and outer membrane 
vesicles are defined by the presence of lipopolysaccharide (LPS). LPS is a three part 




Modification to the structure of this molecule is a well-documented mechanism of enhancing 
bacterial virulence and survival. For example, lipid A modifications or complete loss of the LPS 
have been identified in colistin-resistant species such as Acinetobacter baumannii (16). The O 
antigen consists of up to fifty repeating carbohydrate subunits linked to the core polysaccharide 
of the LPS molecule (6).  This carbohydrate structure functions to stabilize the bacterial cell 
wall, regulate membrane permeability, and protect the bacterial cell by physically hiding other 
outer membrane components from antibodies and complement proteins (11). Because the O 
antigen is the outer most portion of the bacterial cell structure, it is recognized and targeted by 
the host immune system.  
 Loss of the entire O antigen structure can result in reduced immune recognition of these 
bacterial pathogens. O antigen-deficient clinical isolates of Yersinia pestis and P. aeruginosa 
isolates from cystic fibrosis patients have been observed (14, 15). A study analyzing the 
prevalence of O antigen serotypes in 638 K. pneumoniae clinical isolates reported that 8.3 % 
were O antigen-deficient (13). These changes to the LPS structure have been shown to result in 
larger downstream changes to the lipid and protein composition of the bacterial outer membrane 
and secreted vesicles (25, 26). OMVs derived from LPS deficient Neisseria meningitdis are 
known to be enriched in many proteins that are absent from the cellular outer membrane (27). A 
more common modification, such as loss of the O antigen, is sufficient to alter the selection of 
proteins for inclusion in OMVs. For example, the immunodominant, outer membrane proteins 
RagA/B of P. gingivalis are normally absent in wild-type OMVs, but have been identified in 
OMVs lacking the O antigen (26). Therefore the loss of the O antigen may influence the role of 




 The present study investigates the composition of both the outer membrane and outer 
membrane vesicles in K. pneumoniae 43816 and an isogenic mutant in wbbO using a 
comprehensive proteomics-based approach. The wbbO gene codes for the galactosyltransferase 
responsible for the synthesis and attachment of the O antigen to the core polysaccharide (10). We 
hypothesized that a major LPS modification, such as loss of O antigen, would result in distinct 
changes to both the outer membrane and OMVs proteomic profiles. Purified outer membranes 
and OMVs were analyzed by LC-MS/MS generating a dataset of over 1,400 proteins identified 
with high confidence (False Discovery Rate < 1%). It was expected that the protein profiles of 
the OMVs would differ from the source outer membrane. As anticipated many proteins were 
only identified in either the outer membrane or OMVs. When comparing the wild-type to O 
antigen-deficient OMVs, there were numerous proteins that were identified in only the wild-type 
or O antigen-deficient OMVs. To further assess these differences, a smaller dataset was then 
used to more closely analyze the most abundant proteins found in both the secreted vesicles and 
the source outer membrane. We also found that outer membrane proteins and other proteins 
involved in stabilizing or building the cell wall were enriched in OMVs, as compared to the 
source outer membrane for both wild-type and O antigen-deficient K. pneumoniae. It was also 
anticipated that the absence of the O antigen would influence protein sorting into the OMVs. O 
antigen-deficient vesicles exhibited a decrease of outer membrane proteins compared to wild-
type vesicles, but were enriched in protein chaperones. Based on these findings, we concluded 
that the protein content of OMVs differs from that of the outer membrane, and that modification 





Materials and Methods 
Bacterial strains and culture conditions 
 Klebsiella pneumoniae type strain ATCC 43816 and Klebsiella pneumoniae ΔwbbO, an 
O antigen-deficient isogenic mutant of K. pneumoniae 43816, were used in this study. K. 
pneumoniae ΔwbbO was provided by the Younger lab, University of Michigan (10). K. 
pneumoniae strains were cultured in Luria-Bertani (LB) broth, supplemented with 50μg/ml 
kanamycin for the deletion strain, and incubated at 37℃. Growth curves were performed by 
inoculating 1:1000 of overnight cultures into 50 mL of LB broth and the absorbance at 600nm 
(OD600) was measured at thirty minute intervals. 
 
Outer membrane vesicle purification 
 Outer membrane vesicles (OMVs) were purified as previously described (28). Briefly, 6 
liter cultures of each strain were grown to mid-late log phase (OD600 1.5-2.0). Cell free 
supernatants were obtained by differential centrifugation (15 min at 10,000 × 𝑔, then 15 min at 
13,000× 𝑔) and filtration through a 0.65μm PVDF membrane filter (Millipore, Billerica, MA). 
The vesicle-containing supernatants were then concentrated through a tangential filtration 
concentrator unit (Pall Life Science, Ann Arbor, MI) and collected on 100kDa Pellicon filtration 
cassettes (Millipore). Vesicles were then further concentrated in 100kDa MWCO Amicon 
concentrators and reconstituted in 60% Opti-Prep (45% final concentration) (Sigma-Aldrich, St. 
Loius, MO). Vesicles were purified using density gradient centrifugation (OptiPrep/HEPES 
layers of 40, 35, 30, 25, and 20%). After ultracentrifugation (ON at 100,000 × 𝑔), 1 ml fractions 




SYPRO Ruby Red stain. Pure vesicles were pooled, dialyzed overnight in phosphate buffered 
saline, and concentrated to a final volume of 1 ml. 
 
Relative outer membrane vesicle quantification 
 Relative OMV production was assessed by a previously described phospholipid assay 
(42). Briefly, cell free supernatants were collected by centrifugation at 10,000 × 𝑔 and filtered 
through a 0.45 μm membrane. Vesicles were then pelleted by high speed centrifugation (40,000 
x g for 2hr), washed and resuspended in MV buffer (50 mM Tris, 5 mM NaCl, 1 mM MgSO4, 
pH 7.4). An equal volume of chloroform was added and the vesicles were centrifuged at 
6,000 × 𝑔 for 5 minutes. The bottom, organic layer was then collected and treated with an equal 
volume of ammonium ferrothiocyanate solution (27.03 g/L FeCl36H2O, 30.4 g/L NH4SCN). The 
sample was centrifuged again; the bottom layer was collected, and dried under nitrogen gas. 
Dried samples were resuspended in 1mL of chloroform and the absorbance at 470nm was 
measured. Absorbance values were normalized to the OD600 of the originating cultures.  
Outer membrane protein isolation 
  Cell fractionation was adapted from a previously described protocol (43). Briefly, cell 
pellets from 100mL of mid-late log phase cultures were resuspended in Tris-Sucrose solution 
(20mM Tris, 20% sucrose w/v, pH 8.0), and then lysed with lysozyme (40μL lysozyme/g of 
cells) and 0.1M EDTA (0.2mL of EDTA/g of cells). The mixture was incubated on ice and 0.5M 
MgCl2 was added to the lysate. The lysate was centrifuged at 12,000 × 𝑔 for 20 minutes, 
supernatants containing periplasmic proteins was removed, and pellets containing the membrane 




on ice, cellular debris was pelleted (9,000× 𝑔, 5 minutes) and the supernatant containing the 
membranes were then further centrifuged (40,000 × 𝑔, 60 min) to remove cytoplasmic proteins. 
The membrane fractions within the pellet were washed with ice cold Tris, re-suspended in DI 
H2O, and stored at -80℃ Membrane fractions were treated with 1.2mL of sarkosyl solution 
(1.7% sarkosyl w/v, 11 mM Tris), for 20 minutes, and centrifuged at 40,000 × 𝑔 for 90 minutes 
to separate the inner and outer membrane fractions. The pellet containing only the outer 
membrane fraction was washed in ice cold Tris and dialyzed overnight in PBS at 4℃.  
Proteomic sample preparation, digestion, and LC-MS/MS analysis 
  Triplicate samples of both the outer membrane and OMVs from K. pneumoniae 43816 
and ΔwbbO were dissolved in 6 M urea, 50 mM ammonium bicarbonate, 10 mM DTT, and 2% 
SDS. Fifty μg of total protein was alkylated by addition of iodoacetamide to 10 mM and 
incubation in the dark for 30 min before trypsin digestion using the FASP method (44).  
Desalting of tryptic peptides was performed on C18 MacroSpin solid-phase extraction (SPE) spin 
columns (The Nest Group, Inc., Southborough, MA, USA). Samples were lyophilized by 
centrifugation under vacuum and reconstituted in 0.1% formic acid in high-performance liquid 
chromatography (HPLC)-grade water. Five μg total protein was loaded onto a 150 μm ID × 2.5 
cm capillary trap column prior to separation by reverse-phase HPLC on a 75 µm ID × 10 cm 
analytical column – both packed with ProteoPep II C18 (New Objective, Woburn, MA, USA). 
The mobile phases consisted of 0.1% formic acid in water for A and 0.1% formic acid in 
acetonitrile for B. Samples were analyzed by linear gradient elution of 2% - 40% solvent B over 
240 minutes. Full MS scans were performed at normal resolution on a LTQ XL (Thermo 
Scientific, San Jose, CA, USA) with a target of 4 × 104 ions, two microscans, and a 50 ms 




ion-traptarget of 5 × 103 ions and dynamic exclusion set for 180 s with one repeat and a limit of 
500. 
 
Analysis of mass spectral data 
  Raw LC-MS/MS data from K. pneumoniae 43816 and ΔwbbO outer membrane fractions 
and outer membrane vesicles were searched against a K. pneumoniae subset of the European 
Bioinformatics Institute’s (EBI) universal protein resource database (UniProt, 5035 entries) 
using MASCOT (Matrix Science, London, UK; version 2.2.06). Peptide and protein 
identifications were validated on the Scaffold platform (version Scaffold_4.3.2, Proteome 
Software Inc., Portland, OR). Peptide identifications were accepted if greater than 95.0% 
probability as calculated by the Peptide Prophet algorithm (45), while proteins were accepted at 
probabilities greater than 95% as calculated by the Protein Prophet algorithm (46). Proteins 
containing similar peptides were parsimoniously grouped. These parameters resulted in peptide 
and protein confidences at a false discovery rate (FDR) of less than 1.0% . A smaller dataset 
consisting of the top 200 most abundant proteins across all samples was used for comparative 
proteomics analyses. Individual sample classifications were limited to proteins that were 
identified in at least two replicates.  Proteins in each sample were categorized by their cellular 
localization and biological function. Spectral sums and percentages were used to assess relative 
abundance between samples. Cellular localizations of unclassified proteins were predicted using 
PSORTb (47) and biological functions were categorized using cluster of orthologous groups 
(COG) annotation terms (www.ncbi.nlm.nih.gov/COG). Statistical significance of weighted 





Loss of the O antigen does not impact bacterial growth or production of OMVs, but does 
alter the outer membrane protein profile. 
 This study was designed to characterize the effects of O antigen loss on the protein 
composition of the Klebsiella pneumoniae outer membrane (OM) and secreted outer membrane 
vesicles (OMVs). wbbO is the galactosyltransferase involved in the attachment of the O antigen 
to the LPS core (10). Growth curves were performed to evaluate if the inactivation of wbbO and 
resulting absence of the O antigen altered the growth rate of K. pneumoniae. Figure 2.1A shows 
that the deletion of wbbO does not alter the growth rate of the bacteria.  We then quantified 
relative OMV production of each strain to determine if O antigen loss impacted this basic 
physiologic function. OMVs were harvested from overnight cultures, quantified by a 
colorimetric phospholipid assay, and  normalized to the OD600 of the originating culture (42). 
We found that the amounts of OMVs produced by both wild type and O antigen-deficient K. 
pneumoniae were similar (Figure 2.1B). These data demonstrate that O antigen loss does not 




















Figure 2.1 The impact of O antigen loss on cellular growth and relative outer membrane 
vesicle production. (A) Growth curves for Klebsiella pneumoniae 43816 and ΔwbbO 
strains cultured in LB broth. (B) Relative OMV production from overnight cultures 
quantified by phospholipid analysis. Phospholipid content was measured at 470nm and 








 Because LPS is a major component of both the outer membrane and outer membrane 
vesicles, we investigated if loss of the O antigen would impact the protein composition of these 
cellular structures.  As seen in Figure 2.2, the protein composition of both the outer membrane 
and OMVS was altered by loss of the O antigen, resulting in a distinct protein profile in the 
deletion mutant. ΔwbbO OMVs lack many higher molecular weight signals present in both of the 
OM fractions, as well as the wild type OMVs. Additionally, wild type OMVs have a very 
prominent signal around 48kDa that is absent in O antigen-deficient OMVs. These observed 
differences indicate that the absence of the O antigen alters protein expression in both the outer 
membrane and secreted vesicles. Additionally, the protein profiles of the outer membrane and 
OMVs from the wbbO deletion strain are not identical, indicating that proteins increased in the 












                             
Figure 2.2 O antigen loss influences protein expression in the 
outer membrane and outer membrane vesicles. Purified outer 
membranes (OM) and outer membrane vesicles (OMVs) from wild 
type K. pneumoniae and ΔwbbO were resolved by 10% SDS-











Quantitative assessment of outer membrane and outer membrane vesicle proteomes 
 To fully characterize the changes in protein profiles observed in Figure 2.2, we used LC-
MS/MS to characterize the OM, and OMV sub-proteomes of K. pneumoniae 43816 and the 
ΔwbbO mutant. This generated a dataset of over 1,400 proteins identified with high stringency (< 
1.0% FDR). This dataset consisted of 1,334 OM and 1,130 OMV proteins. When comparing the 
wild type and the deletion strains, 1,057 and 649 proteins were commonly identified in either the 
outer membrane or the OMVs (Figure 2.3A & 2.3B). Interestingly, many proteins common to 
both the OM and OMVs were only identified in either the wild-type or O antigen-deficient K. 
pneumoniae, indicating the profound impact of O antigen loss on the protein composition. As 
shown in Figure 3B, only 649 of the 1,130 OMV proteins were common to both strains, with 
many proteins exclusively found in secreted vesicles from the ΔwbbO strain (n=284) or the wild 
type (n=197). When comparing the source outer membrane to their OMVs, many proteins were 
solely found in the cellular OM of either strain (wild type n=513 or Δwbbo n=354) (Figure 2.3C 
& 2.3D). Likewise, the OMV proteome consists of many proteins that are absent in the source 
OM in wild type (n=98) and O antigen-deficient (n=157) OMVs. These data further support our 
hypothesis that the loss of the O antigen dramatically impacts not only the composition of the 
outer membrane itself, but also has a significant effect on which proteins are selectively 







Figure 2.3 Semi-quantitative evaluation of the OM and OMV proteome of K. pneumoniae 
43816 and ΔwbbO. Proteins were evaluated by LC-MS/MS and analyzed in SCAFFOLD 
Q+S generating a 1,400 protein dataset. Scaffold Q+S software was used to evaluate 
general quantitative comparisons between the numbers of proteins identified in (A) 43816 
and ΔwbbO outer membranes, (B) outer membrane vesicles, and outer membrane and outer 
membrane vesicle quantitative comparisons for K. pneumoniae (C) 43816  and (D) ΔwbbO. 
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The O antigen influences packaging of outer membrane proteins into vesicles 
 This study focused on identifying the most significant changes to the protein composition 
within the OM and OMVs as a result of O antigen loss. For this more focused analysis, we 
generated a smaller dataset representing the top 200 proteins with the highest spectral counts 
across all samples (Table S1). The proteins excluded from this data subset either had very low 
spectral counts or were proteins that were only identified in one replicate and were not identified 
in other samples.  This dataset was used for both quantitative and qualitative assessments of the 
cellular localizations and functional classification of these top 200 proteins.  
  The cellular locations of proteins found in OMVs were first assigned by either their 
designation in UNIPROT, or predicted using PSORTb (47). Analysis of this subset revealed that 
outer membrane proteins represented a lower percentage of the total spectra in O antigen-
deficient vesicles compared to wild type OMVs (Figure 2.4A). Loss of O antigen resulted in a 
statistically significant (p=0.014) decrease in the amount of outer membrane proteins in ΔwbbO 
OMVs compared with OMVs from the wild-type strain (Figure 4B). There were no significant 
differences in outer membrane protein enrichment between the cellular outer membranes. 
However, when comparing outer membrane proteins from the cellular outer membrane to those 
in the OMVs, we see a significant difference in the degree of this selective packaging. Across 
both the wild type and the mutant strains, outer membrane proteins are enriched in OMVs as 
compared to the source OM (Figure 4B). Vesicles from wild type K. pneumoniae demonstrated 
statistically significant enrichment in outer membrane proteins (p=0.001) compared to the source 
outer membrane, while ΔwbbO outer membrane protein enrichment in OMVs did not (p=.083). 




and demonstrate how this selective packaging process can be altered by loss of the O antigen 
(18, 25, 30).  
 Given this significant change in the proportion of outer membrane proteins in vesicles, 
we then assessed the cellular localization and functional classifications of all proteins from our 
200 protein dataset (Table S1). We first categorized OMV proteins by their cellular localization 
(Figure2. 4A). This analysis confirmed our earlier result that outer membrane vesicles are 
enriched in outer membrane proteins, and also revealed the presence of many cytoplasmic 
proteins.  Outer membrane (n=25) and cytoplasmic proteins (n=77) represent 46.7% and 45% of 
the total spectra in vesicles from wild type K. pneumoniae. In the ΔwbbO strain, the number of 
outer membrane proteins (n=25) is the same as wild-type. However, the overall abundance of 
these same proteins is decreased in ΔwbbO OMVs where outer membrane proteins only 
represent 24.8% of the total spectra (Figure 2.4A). Cytoplasmic proteins, many of which can also 
be found in the periplasm, are more highly enriched in ΔwbbO OMVs (n=90) than those of the 
wild-type strain. Additionally, a small number of inner membrane proteins (n=13; n=9) were 
identified in both the wild type and ΔwbbO OMVs. Many of these inner membrane proteins are 
peripheral membrane proteins and not directly tethered to the inner membrane itself, allowing for 
their movement into secreted vesicles. Surprisingly, only 2% and 5.5% of the proteins identified 
in this smaller dataset were periplasmic proteins in ΔwbbO and wild type OMVs, respectively. 
These data demonstrate that loss of the O antigen has a significant effect upon the protein 
composition of outer membrane vesicles, resulting in vesicles that contain a greater abundance of 












Figure 2.4 Loss of the O antigen alters outer membrane protein composition in outer 
membrane vesicles.  (A) Percent of total spectra by cellular location of K. pneumoniae 
43816 and ΔwbbO outer membrane vesicles. (B)  Relative quantification of outer 
membrane proteins in OM and OMVs from K. pneumoniae 43816 and ΔwbbO. Statistical 
significance of weighted spectral sums was assessed by single factor ANOVA (* p<0.05, 
** p<0.001). Significance between groups is represented by horizontal brackets. Error bars 














Functional classification of proteins in outer membrane vesicles and the cellular outer 
membrane 
 The top 200 most abundant spectra were then used to assign COG functional 
classifications to proteins (www.ncbi.nlm.nih.gov/COG). Table 1 reports the percentage of 
spectra for each category from either outer membrane or outer membrane vesicles. The 
percentage of total spectra was used to evaluate the proportional representation of proteins from 
each category in the respective sample. COG category “M” includes proteins involved in cell 
wall/membrane/envelope biogenesis which are highly abundant in OMVs from both strains, as 
well as in the outer membrane of the ΔwbbO strain. The majority of the proteins belonging to 
COG category “M” are localized in the outer membrane (Table S1). The percent spectra of 
category M further demonstrates enrichment of proteins from this category in OMVs over the 
outer membrane itself, and less in the OMVs from the ΔwbbO strain compared to the wild type 











Table 1. COG functional classification of outer membrane vesicle and cellular outer membrane 









 To determine the importance of the changes in these functional categories, single factor 
ANOVA was used on spectral sums for each COG category to assess statistical significance 
between samples. As seen in Figure 2.5A, there was a statistically significant difference in the 
abundance of proteins from COG category “M” between wild type vesicles and the source outer 
membrane. There is also a near significant (p=0.07), difference between COG category M 
protein abundance between wild-type and O antigen-deficient OMVs (Table S2).  
 Many of the COG category “M” proteins that are enriched in OMVs are major outer 
membrane porins such as OmpA, OmpK35, and OmpK36. Outer membrane proteins not 
associated with transport, such as murein lipoprotein, SlyB, Tsx, and YfaZ were also 
significantly enriched (p<0.05) in OMVs from both strains (Table S2). In the vesicles derived 
from the ΔwbbO strain, all of the previously described outer membrane proteins are less 
abundant than in the wild type OMVs. The spectral counts of OmpA, OmpK17, TolC, MipA, 
YfaZ were significantly lower in OMVs from the ΔwbbO strain, indicating that the O antigen 
influences protein integration into OMVs (Table S2).  
 Consistent with our observation of increased outer membrane protein enrichment in wild-
type vesicles, OmpA, OmpK17, TolC, MipA, and BtuB all had statistically significant increases 
in spectral counts when comparing vesicles to source membrane in the wild type strain (Tables 
S1 and S2). Proteins YfaZ and BtuB were almost entirely present in OMVs having very low 
spectra from the OM fractions, demonstrating the potential for extreme enrichment in vesicles 













Figure 2.5 Abundance of COG functional category “M” and “O” proteins. Weighted 
spectral sums of proteins involved in (A) cell wall/membrane/envelope biogenesis 
(Category “M”), and (B) PTM, protein turnover, and chaperones (Category “O”) were 
averaged between replicates. Statistical significance was based on individual 
weighted spectral counts and assessed by ANOVA (* = p <0.05). Significance 











 When comparing the cellular OM fractions, the major outer membrane proteins were 
slightly enriched in ΔwbbO OM samples (Figure 2.4B & 2.5A). One possible explanation for the 
difference in protein levels between the wild type and the knockout strain is that deletion of 
wbbO results in altered levels of total cellular production of many of these outer membrane 
proteins. In order to confirm that the ΔwbbO mutation is not altering outer membrane protein 
transcription through a secondary mechanism of gene regulation, RNA was extracted from mid-
late log phase cells to quantify relative outer membrane protein transcript levels (OmpA, 
OmpK35, and OmpK36) via qPCR. K. pneumoniae ΔwbbO outer membrane protein transcript 
levels were slightly, but not significantly, down-regulated compared to wild type K. pneumoniae 
(data not shown). These data indicate that deletion of the wbbO gene is not altering outer 
membrane protein gene expression to the degree that is observed in our proteomic analysis. 
O antigen-deficient OMVs are enriched in chaperones 
 K. pneumoniae ΔwbbO OMVs exhibit decreased outer membrane protein cargo and 
increased numbers of  proteins involved in post-translational modification, protein turnover, and 
chaperones (COG category “O”) (Figure 2.5B). Many of these proteins are chaperones involved 
in protein turnover of the cellular envelope (Table S1). In particular, GroEL, a cytoplasmic 
protein known to be associated with the outer membrane of K. pneumoniae and other Gram-
negative bacteria (48-50), was the most prominent protein found in ΔwbbO OMVs, and was the 
third most abundant in wild-type OMVs. When compared to wild type K. pneumoniae, GroEL 
levels in the ΔwbbO strain were highly enriched in both the OM and OMVs (Figure 2.6A & 




were also enriched in ΔwbbO OMVs. DnaK enrichment was only observed in the OMVs derived 
from ΔwbbO (Figure 2.6B), while GroEL and DegP exhibit enrichment in vesicles from both 
strains. DegP was highly enriched in OMVs from both strains, and the level of DegP enrichment 
in ΔwbbO OMVs was statistically greater than DegP levels in ΔwbbO OM (Figure 2.6C). This 
indicates that chaperone production and packaging into vesicles may be a compensatory role for 


















                             
 
          
 
Figure 2.6 Chaperone enrichment in K. pneumoniae ΔwbbO outer membrane vesicles. Weighted 
spectra of the chaperones (A) GroEL, (B) DnaK, and (C) DegP  were averaged between 
replicates. Statistical significance was based on individual weighted spectral counts and assessed 
by ANOVA (* = p <0.05). Significance between groups is represented by horizontal brackets. 









 The goal of this study was to compare and characterize the sub-proteomes from both the 
outer membrane and secreted outer membrane vesicle (OMVs) of Klebsiella pneumoniae. 
Additionally, we characterized how a single mutation, resulting in the loss of LPS O antigen 
impacted the packaging of protein cargo into outer membrane vesicles.  This comprehensive 
proteomic study is the first to directly compare the outer membrane and OMV sub-proteomes in 
K. pneumoniae. Our findings support the hypothesis that a selective sorting process is utilized to 
direct packaging of protein cargo from the outer membrane into OMVs.  This sorting process is 
altered by O antigen loss, with fewer outer membrane proteins, but more chaperones, packaged 
into O antigen-deficient OMVs. Together, the proteomic analyses presented in this study 
demonstrates that LPS modification impacts the process of packaging cargo into secreted 
vesicles. 
 We initially hypothesized that such a major modification to the structure of LPS as O 
antigen loss would have a significant effect on either the rate of bacterial growth or the rate of 
outer membrane vesicle production. However, this was not the case, as neither the growth rate 
nor the rate of OMV production was significantly impacted by this isogenic mutation.  Other 
studies targeting the wbbO gene in Klebsiella have also observed no change in growth rate (3). O 
antigen-deficient Pseudomonas aeruginosa (ΔWbpM) was reported to a have lower stationary 
phase cell density in the O antigen mutant, however, this could be attributed to the inactivation of 





 In agreement with previous findings, the absence of the O antigen was not observed to 
alter OMV production (25, 26). However, while the loss of the O antigen does not affect these 
basic physiological processes, alterations to the protein composition of both the outer membrane 
and secreted outer membrane vesicles were observed in our experiments. These data demonstrate 
how the deletion of a single gene in the LPS synthesis pathway can result in large-scale 
reorganization and compensatory changes to the outer membrane. 
 The total protein composition of both the outer membrane and naturally secreted outer 
membrane vesicles were evaluated by LC-MS/MS analysis. In order to have a highly 
comprehensive analysis, we utilized the FASP method to process the total protein content of both 
the outer membrane and OMVs. This method allowed us to also identify lower abundance 
proteins that are often omitted when excising proteins from gels. This analysis resulted in an 
initial protein dataset of 1,400 proteins identified with high confidence, which greatly expands 
the known outer membrane vesicle proteome of Klebsiella pneumoniae.  To date, there has only 
been one other proteomic study conducted on K. pneumoniae OMVs. Although the study by Lee 
et al. (2012), demonstrated that K. pneumoniae OMVs elicit the murine innate immune response, 
the proteomic analysis of this study was limited to excised samples from a protein gel, resulting 
in a small dataset of only 159 proteins (30).  Even with this limited dataset, a number of proteins, 
including MipA, Lpp, and DegP were found in common with our data. Interestingly, Lee et al. 
(2012), reported that OmpX, or OmpK17, was the single most abundant outer membrane protein 
in their OMVs, whereas we identified OmpA as being the most abundant. Beyond the differences 
in methodology, this discrepancy could be attributed to strain specific variations in K. 
pneumoniae, or the possibility that the OMVs were harvested from different stages in bacterial 




 An initial evaluation of our large dataset revealed that many proteins were present in 
higher concentrations in either the outer membrane or secreted vesicles. The protein profiles of 
OMVs are known to be distinct from those of the outer membrane, and a selective sorting 
mechanism has been suggested to be involved in OMV formation (25-27). Initial quantitation of 
this large dataset confirmed that the protein profiles of the OMVs in K. pneumoniae are distinct 
from those of the outer membrane, supporting this current hypothesis. To evaluate the 
differences in the outer membrane and OMV sub-proteomes in more detail, we utilized a smaller 
dataset of the top 200 proteins across all samples.  This more detailed analysis revealed that, like 
many other bacterial species, wild-type OMVs from K. pneumoniae are highly enriched in outer 
membrane proteins, while cytoplasmic and periplasmic proteins represent a smaller proportion of 
OMV cargo (18, 25, 26, 30). In our O antigen mutant, we see a dramatic increase in OMV cargo 
originating in the cytoplasm as compared to wild-type OMVs. This alteration of the relative 
content indicates that the O antigen does contribute to the process of cargo sorting and selection 
into OMVs. 
 The majority of the proposed mechanisms for the production of outer membrane vesicles 
focus on the actions of proteins from COG category “M”. The enrichment of proteins from this 
functional category is common to OMVs from many Gram-negative bacterial species (18, 39, 51, 
52).  In particular, Lpp and OmpA, which both act to create stabilizing linkages between the 
outer membrane and the peptidoglycan layer, are thought to be critical regulators of this process 
(53). Deletion mutants of either of these two proteins result in a hyper-vesiculation phenotype 
(54-56), while down-regulation of OmpA by the small RNA VrrA has been associated with 




 OmpA was the most abundant outer membrane protein identified in all samples and was 
highly enriched in OMVs.  However, the enrichment of proteins such as OmpA, TolC, Lpp, and 
MipA, was much less pronounced in the O antigen-deficient strain of K. pneumoniae. The 
pronounced level of OmpA in all samples, and the lack of change in the rate of vesicle 
production indicate that the loss of O antigen does not directly impact the rate of vesicle 
production, but may instead impact the selection of cargo to be packaged into vesicles.  
 There have been discrepancies regarding whether cytoplasmic proteins are normal 
constituents in the lumen of OMVs or an artifact of cellular lysis. Much of this discussion has 
been based on the results of early studies of bacterial vesicles that utilized harsh treatments to 
artificially generate outer membrane liposomes, or relied on less rigorous purification protocols. 
Studies such as this one, which follow standardized purification methods, utilizing density 
gradients to remove cellular debris, have confirmed that some cytoplasmic contents are normal 
components of outer membrane vesicles (37, 58, 59). Most of the cytoplasmic proteins found in 
OMVs in this study, including GroEL (Hsp-60) and EfTu, are commonly seen in vesicles 
purified from bacterial species. Additionally, many of these proteins have more recently been 
observed on the bacterial outer surface, indicating that trafficking of proteins from the cytoplasm 
to the outer surface may be a component of vesicle formation (60).  
 Deletion of the wbbO galactosyltransferase resulted in large scale alterations to the 
composition of the outer membrane beyond just the truncation of LPS polysaccharides. The 
protein composition of both the outer membrane and secreted vesicles was significantly altered 
by this single deletion. Even with this alteration, many outer membrane proteins remained 
enriched in ΔwbbO OMVs, with 25 outer membrane proteins common to both wild-type and O 




significantly less in ΔwbbO OMVs than the wild type. Outer membrane proteins represented 
approximately 25% of proteins identified in ΔwbbO OMVs, as compared to 46.7% 
representation in wild-type OMVs.  In fact, while enrichment of outer membrane proteins from 
the OM to OMVs was still apparent in the mutant strain, this decrease in the level of enrichment 
resulted in the OMVs no longer being statistically different from their source membrane.  This 
change in the outer membrane protein content upon alteration of LPS is consistent with studies 
of other mutants, such as the deletion of the wbpM epimerase/dehydratase in Pseudomonas (25) 
and LPS deficient  Neisseria  (27). Together these studies all indicate that the structure of LPS 
directly impacts the selection of protein cargo during vesicle formation. 
 Haurat et al. (2011), completed a similar study investigating the packaging of gingipains 
into the outer membrane vesicles of P. gingivalis. In contrast to the present and other data, they 
found that deletion of either the porS flippase, or the waaL ligase, did not significantly impact 
outer membrane protein composition, but did alter cargo selection for vesicles (26). P. gingivalis 
normally contains two varieties of LPS, O and A chain, with one of these natural variants lacking 
the O antigen entirely. This key difference in membrane lipid content can explain how the 
protein content of the P. gingivalis outer membrane is not greatly altered, unlike the results seen 
in our study.  The more modest changes seen in the P. gingivalis membrane may reflect the 
moderating effect of altering some, but not all, LPS in the bacterial cell.  
 Even with these more modest changes to the source membrane, Haurat et al. (2011), did 
demonstrate significant changes to OMV protein cargo, and proposed a mechanism for sorting 
and packaging of proteins into OMVs that requires direct interaction between the O antigen 
sugars and the proteins to be packaged (23, 26). Our data supports the hypothesis that O-antigen 




not the sole mechanism of sorting; as enrichment of outer membrane proteins also occurs in our 
O antigen-deficient strain, albeit to a reduced degree.  We confirmed via Real-Time PCR that 
expression of the major outer membrane proteins is not impacted by O antigen loss, and levels of 
these proteins are similar in the source outer membranes of both the wild-type and deletion 
strains. Therefore, this reduction of OMP content in secreted vesicles is not due to reduced 
expression of these proteins, nor reduced content in the source membrane. 
 The previously mentioned model has been proposed for bacterial species that express A 
band (neutral) and B-band (charged) LPS, such as P. aeruginosa and P. gingivalis (25, 26). It is 
hypothesized that charged O antigen residues may directly affect the integration of certain 
protein cargo into OMVs (23, 29). Proteins containing a yet-to-be identified microdomain may 
have a strong affinity for the charged O antigen, leading them to directly interact with the O 
antigen, resulting in packaging as protein cargo during the budding and release of OMVs from 
the membrane. However, this model is limited to bacterial species with known charged LPS 
chemotypes. In most enteric bacteria, the phosphates of the inner core, rather than the O antigen, 
are responsible for the net negative charge of the LPS molecule (61). However, in K. 
pneumoniae, the core oligosaccharide differs from other Enteric’s because it lacks these charged 
phosphates, and instead contains GalU residues that are responsible for the net negative charge. 
These variations in molecular structure would have a direct impact on protein sorting into OMVs 
using the current proposed model. Further, it has been reported that E. coli, Salmonella, and 
Klebsiella deep rough mutants, which lack the core phosphates or GalU residues, had decreased 
outer membrane protein content indicating that the core of the LPS molecule may be involved in 
the folding and integration of OMPs into the membrane (61-66). Finally, secondary sorting 




proteins resulting in selective sorting into OMVs (23, 29). Our data support the idea of the LPS 
molecule being critically involved in the process of cargo sorting, but not being the sole player in 
this function. 
 The loss of the O antigen resulted in OMVs with reduced levels of proteins from COG 
category “M”, but were significantly enriched in COG category “O” proteins involved in post-
translational modification, protein turnover, and chaperones; whether periplasmic or 
cytoplasmic. GroEL, a cytoplasmic chaperone also known to be a surface associated protein, was 
the most abundant protein identified in both the outer membrane and OMV of the ΔwbbO strain, 
and had been identified as a significant component of vesicles from A. baumannii and F. 
novicida (67, 68). While GroEL has classically been considered a cytoplasmic chaperone, there 
is an increasing amount of data demonstrating that this protein can be associated with the outer 
surface of both Gram-positive and Gram-negative bacterial species (40, 48, 49). Cytoplasmic 
GroEL functions as a chaperone that modulates protein folding; but surface associated GroEL 
has been shown to promote host inflammation and phagocytosis of several bacterial species (48, 
50, 69).  GroEL expression is known to increase in response to environmental stress and the 
significant enrichment of this protein in ΔwbbO OMVs could likely be a compensatory role for 
physiologic stress as a result of LPS modification.  
 The accumulation of mis-folded proteins and proteinaceous waste in the periplasm has 
been well documented to trigger the envelope stress response and increase formation of OMVs 
(70). It is therefore unusual that the ΔwbbO strain did not exhibit increased vesicle formation, but 
rather had vesicles with increased chaperones and proteases, such as DnaK and DegP.  
Additionally, we observed decreased levels of outer membrane proteins in vesicles, but not the 




vesicles of the mutant strains, or if they are being degraded by the more plentiful chaperones and 
proteases. The enrichment of these chaperones in ΔwbbO outer membrane vesicles may serve to 
remove mis-folded outer membrane proteins that otherwise would be removed via OMVs. This 
hypothesis would explain why we do not observe a hyper-vesiculating phenotype, as periplasmic 
turgor pressure could be relieved by degradation of proteins within the periplasm itself.  
 In particular, DegP, a dual function periplasmic chaperone and temperature-dependent 
protease, may play a significant role in this compensatory response (53, 71). DegP mutants have 
been well established to produce hyper-vesiculating phenotypes (70, 72). In the current study we 
found that DegP was enriched in OMVs from both the wild-type and mutant strains; and was 
more abundant in O antigen-deficient OMVs. Increased DegP content may in fact represent a 
compensatory mechanism to adjust for the inability of outer membrane proteins to be properly 
sorted into OMVs for secretion out of the cell. The degradation of OMPs by DegP would explain 
why the wbbO mutant does not produce a hyper-vesiculating phenotype.  Further studies 
focusing on the interactive effects of mutants in degP or other proteases and wbbO together are 
needed to clarify the role that each plays in controlling OMV cargo selection and formation. 
 In conclusion, this is the first comprehensive study analyzing both the outer membrane 
and OMV sub-proteomes in Klebsiella pneumoniae. This study provides strong support to the 
existence of a selective sorting mechanism for the integration of proteins into OMVs. This study 
also demonstrated how the absence of the O antigen from the cell surface impacts this selective 
sorting mechanism. While our data indicate that the carbohydrate portion of the LPS molecule 
may play a significant role in proteins sorting for OMVs across species, it also demonstrates how 
molecular variations to this structure may impact the sorting process. The decreased presence of 




physiologic adaptations other than increased OMV production may occur in response to the loss 
of the O antigen. Future studies will focus on determining how the mechanisms of cargo sorting 













                          
Chapter 3 
Inflammatory Responses Elicited by the Cellular Outer Membrane and Secreted Outer 



















 Gram-negative bacteria naturally release outer membrane vesicles (OMVs) during all 
stages of cellular growth (18). OMVs are 20-200nm spherical bilayers released from the outer 
membrane and therefore contain outer membrane components such as lipopolysaccharide (LPS), 
phospholipids, and outer membrane proteins as well as periplasmic and cytoplasmic proteins 
within their lumen (19). The production of OMVs removes over-expressed or mis-folded 
proteins to relieve bacterial envelope turgor pressure (19). Toxic compounds such as attacking 
phages or host antimicrobial peptides can be removed from the bacterial cell through the release 
of OMVs (20). Vesicles are also involved in cell-to-cell communication and have been known to 
be involved in the transfer of antibiotic resistance enzymes and horizontal gene transfer between 
bacterial species (21, 22).  
 Common components of OMVs are pathogen associated molecular patterns (PAMPs) 
such as LPS and outer membrane proteins that stimulate host immune responses. LPS is 
important for the maintenance and integrity of the outer membrane and contains molecular 




of the lipid A, core oligosaccharides, and the O antigen. The lipid A portion of the molecule is 
integrated into the bacterial outer membrane and has a structure that is conserved among Gram-
negative, enteric bacteria (6). Lipid A acts as a PAMP for toll-like receptor 4 (TLR-4), the 
pattern recognition receptor on the surface of phagocytic cells. The interaction between LPS and 
the TLR-4-CD14-MD2 complex results in the activation of NF-κB and the production of 
inflammatory cytokines (8, 9). 
 Although LPS is the Gram-negative endotoxin responsible for activation of the 
inflammatory response, LPS modifications are commonly observed in pathogenic bacteria. For 
example,  E. coli and Salmonella thyphimurium, can exhibit mutations in the genes responsible 
for the synthesis and attachment of the O antigen resulting in a rough LPS phenotypes (12). 
Cystic fibrosis patients have been observed with O antigen-deficient strains of P. aeruginosa 
(14). Yersinia pestis, causative agent of the plague, is an exclusively O antigen-deficient 
bacterium (15). Other pathogens, such as strains of Acinetobacter baumannii and Neisseria 
meningitis, have been isolated lacking LPS entirely (16, 17).  
 Modifications to the LPS endotoxin, such as O antigen loss, alter host immune responses.  
It has been demonstrated both in vitro and in vivo that pathogens displaying a rough LPS 
phenotype have altered immune responses compared to bacteria containing smooth LPS (32-35). 
Smooth LPS requires LPS binding protein and the CD14 receptor to activate the production of 
inflammatory cytokines. Rough LPS, lacking an O antigen, can initiate the production of 




interacting with TLR-4 and MD-2 (33, 35). These studies demonstrated that the absence of the O 
antigen alters host immune responses. However, the previously described studies used 
chemically extracted LPS and it has been shown that vesicle-bound LPS and protein cargo 
produced a significantly stronger inflammatory response when compared to purified LPS (31, 
73).  
 Because OMVs are highly enriched in LPS, modifications to the LPS would also impact 
the immune response to OMVs. Vesiculation is the main LPS delivery mechanism that Gram-
negative pathogens employ during an infection, however, LPS is not the sole molecule 
responsible for activating the inflammatory response. OMVs are also enriched in other bacterial 
PAMPs such as outer membrane proteins that along with LPS, synergistically activate the OMV 
mediated immune response (31, 74).  LPS modifications also cause variation to the protein 
components of the outer membrane. It has also been demonstrated in P. aeruginosa and P. 
gingivalis that the absence of the O antigen alters the protein cargo found in OMVs (25, 26). 
Therefore O antigen loss and resulting changes to the protein content of the membrane could 
drastically alter the inflammatory response to OMVs. 
 OMVs are formed and released from the cellular outer membrane suggesting that the 
OMV content is reflective of the outer membrane (18, 23). Although the OMVs are derived from 
the cellular outer membrane, the protein content of OMVs is not identical to the protein content 
of the cell. In the previous chapter, we demonstrated that OMV protein profiles are distinct from 
those of the outer membrane in K. pneumoniae. Specifically we demonstrated that outer 
membrane proteins involved in building and stabilizing the cell envelope were highly enriched in 
OMVs compared to the cellular membrane. The previously described proteomic study also 




O antigen-deficient OMVs were less abundant in outer membrane proteins compared to wild 
type OMVs, but were highly enriched in chaperones.    
 LPS modifications and OMV production occur simultaneously during infections and 
should be evaluated together to understand the pathogenicity associated with K. pneumoniae. 
Currently there is only one study evaluating the immune response to K. pneumoniae OMVs, 
however, this study did not include a side-by-side analysis of the OM and OMV immune 
responses (30). The purpose of the current study was to compare the inflammatory responses 
elicited in macrophages treated with cellular outer membrane fractions or purified OMVs from 
K. pneumoniae 43816 or an isogenic mutant in wbbO lacking its O antigen. Because OMVs are 
highly enriched in outer membrane proteins which are known to enhance the inflammatory 
response, it is predicted that the OMVs will produce a much more potent inflammatory response 
than the cellular outer membrane. It is also anticipated that O antigen-deficient K. pneumoniae 
OM and OMVs will produce distinct inflammatory responses compared to the wild type strain. O 
antigen-deficient OMVs contained a reduced amount of outer membrane proteins compared wild 
OMVs. Interestingly OMVs lacking their O antigen were highly enriched in chaperones, which 
are also known to stimulate the inflammatory response, making it difficult to predict whether the 
loss of the O antigen will strengthen or dampen the inflammatory response.  
Materials and Methods 
Bacterial Culture Conditions, Purification of Outer Membrane Vesicles and Outer 
Membrane Fractions  
 K. pneumoniae strains 43816 and ΔwbbO growth conditions, and OMV and outer 




Macrophage Culture and assay set up 
 RAW246.7 or MH-S murine macrophages were grown in RPM1 media supplemented 
with 10% fetal bovine sera and penicillin-streptomycin-amphotericin B. Cells were grown at 
37℃ with 5% CO2 for all experiments. Confluent RAW 246.7 cells were seeded into a 96 well 
plate (1 x105 cells per well) and treated with either  wild type or O antigen-deficient OMVs or 
OM fractions at varying concentrations based on protein content (0.01 μg/ml, 0.001 μg/ml, 
0.0001 μg/ml) for 3 hours. Untreated macrophages were used for the control group. 
Macrophage Responses and Inflammatory Cytokine Production 
 Total RNA was collected from macrophages using the RNeasy Kit and purified with a 
DNase treatment to remove any residual DNA (Qiagen, Valencia, CA). cDNA was synthesized 
from 1 μg of mRNA using an oligo(dT)16 primer (Operon, Huntsville, AL) and Protoscript II 
according to the manufacturers protocol (New England bioscience). PCR products were purified 
using the QIAquick PCR Purification Kit (Qiagen). Real-Time PCR assays were performed 
using LuminoCt SYBR® Green qPCR ReadyMix on a Eppendorf RealPlex2 unit. Cytokine gene 
expression was normalized to actin expression and relative gene expression was quantified using 
the ΔΔCT method (24). To confirm that the mature cytokine gene products are being secreted by 
macrophages, the culture supernatants were collected and cytokine protein production was 
quantified by enzyme linked immunosorbent assay (ELISA, R&D Systems/BD) according to the 
manufacturer’s protocol. Statistical comparisons between groups will be evaluated using the 







 Proteomic analysis of outer membrane (OM) and outer membrane vesicles (OMVs) 
derived from wild type and O antigen-deficient Klebsiella pneumoniae revealed that the OM and 
OMV sub-proteomes are distinct from one another. In chapter two, we sought to evaluate if the 
distinct protein profiles observed between the OM and OMVs would result in different 
inflammatory responses. RAW 264.7 murine macrophages were treated with sequential dilutions 
of either purified OMVs or OM fractions isolated from wild type (43816) and an O antigen 
mutant (ΔwbbO) K. pneumoniae.  After a 3 hour incubation, gene expression and cytokine 
protein secretion were assessed. Relative gene expression of inflammatory cytokines was 
quantified by Real-Time PCR using the 2ΔΔct (75). Gene expression was normalized with actin 
and is represented as the fold increase to the untreated control. To confirm cytokine protein 
production and secretion from macrophages, media was collected and assayed by direct 
sandwich ELISA. IL-6, MIP-2, IL-1β, GM-CSF, TNF-α, and iNOS are primary mediators of the 
inflammatory response elicited by Gram-negative bacteria and were assayed to quantify the 
inflammatory responses elicited by K. pneumoniae.  
Wild type outer membrane vesicles stimulate a stronger inflammatory response than the 
cellular outer membrane  
 To compare the inflammatory responses elicited by K. pneumoniae cellular OM and 
secreted OMVs, cytokine gene expression was quantified from macrophages treated with 
sequential dilutions of wild type OM and OMVs. All treatments resulted in significant up-
regulation and secretion of these gene products. It has been shown that LPS stimulates IL-1β 




oxide synthase which produces nitric oxide used in macrophage oxidative burst. iNOS and IL-1b 
were only assayed by Real-Time PCR because neither of these inflammatory mediators produces 
a secreted, detectable protein product during the inflammatory response. As determined by both 
Real-Time PCR (Figure 3.1) and ELISA assay (Figure 3.2), OMVs stimulate a significantly 
more potent inflammatory response across all genes assayed than do purified OMs. The 
difference in these responses increased with decreasing bacterial dose, indicating the potency of 
these naturally secreted products. These significant differences were most apparent using the 
ELISA assay, indicating that post-transcriptional regulation of active secretion of these genes 
products may further amplify these responses. Transcriptional responses were most similar at the 
highest dose (0.01ug protein), which may indicate a saturation effect. Regardless, these doses 
still elicited significantly different levels of protein production.  These data clearly demonstrate 
that the distinct composition of OMVs relative to the source membrane is recognized by 












             
                 
 
                    
Figure 3.1 Wild type K. pneumoniae OMVs elicit a more potent inflammatory responses than 
the cellular OM. RAW 264.7 murine macrophages were treated with varying doses based on 
protein content of either the OM or OMV from K. pneumoniae 43816. Cells were incubated for 3 
hrs and gene expression was quantified by real-time PCR for MIP-2 (A), TNF-α (B), GM-CSF 
(C), IL-1β (D), IL-6 (E), and iNOS (F). Error bars represent the SEM (n ≥ 4). Statistical 








                    
 
 
                  
 
Figure 3.2  Wild type K. pneumoniae outer membrane vesicles stimulate a stronger responses 
than the cellular OM. RAW 264.7 murine macrophages were treated with increasing doses based 
on protein content of OM fractions or OMVs from K. pneumoniae 43816. Cells were incubated 
for 3 hrs and the culture media supernatants were collected and cytokine protein secretion was 
quantified by ELISA assays for MIP-2 (A), TNF-α (B), GM-CSF (C), and IL-6 (D). Error bars 
represent the SEM (n ≥ 5). Statistical significance between groups is represented by horizontal 







O antigen-deficient outer membrane vesicles also stimulate a stronger inflammatory 
response than the cellular outer membrane  
 The previous proteomic study demonstrated that inactivation of the wbbO gene, 
responsible for the synthesis and attachment of the LPS O antigen, altered the protein profiles of 
the OM. Wild type OMVs elicited a stronger inflammatory response compared to the cellular 
OM. To confirm that this trend was also observed in the O antigen mutant, the inflammatory 
response generated from K. pneumoniae ΔwbbO OM and OMVs were also evaluated. As seen in 
Figure 3.3 and Figure 3.4, both inflammatory cytokine gene expression and protein secretion 
were significantly increased by treatment with the OMVs rather than the cellular OM. The 
lowest dose (0.0001 μg) displayed the greatest differences between the O antigen-deficient OM 
and OMV samples. At this dose cytokine gene expression was significantly higher due to 
treatment with ΔwbbO OMVs indicating that OMVs maintain their potency at lower doses 
(Figure 3.3). The differences between the potency of the OM and OMVs are further 
demonstrated by the amount of cytokine protein product secreted from macrophages. Compared 
to the cellular OM components derived from the ΔwbbO strain, cytokine protein production was 
greatly elevated by ΔwbbO OMV treatment for all proteins quantified (Figure 3.4). The results of 
this study confirm that distinct protein profiles of the OMVs results in a drastically increased 







                    
 
                  
 
                      
 
Figure3.3 O antigen-deficient K. pneumoniae OMVs elicits a more potent inflammatory 
responses than the cellular OM. RAW 264.7 murine macrophages were treated with varying 
doses of either the OM or OMV from K. pneumoniae ΔwbbO. Cells were incubated for 3 hrs and 
gene expression was quantified by real-time PCR for MIP-2 (A), TNF-α (B), GM-CSF (C), IL-
1β (D), IL-6 (E), and iNOS (F). Error bars represent the SEM (n ≥ 4). Statistical significance 







                  
                  
                    
          
 
 
Figure 3.4 O antigen-deficient K. pneumoniae outer membrane vesicles stimulate a stronger 
responses than the cellular OM. RAW 264.7 murine macrophages were treated with different 
protein based doses of OM fractions or OMVs from K. pneumoniae ΔwbbO. Cells were 
incubated for 3 hrs and the culture media supernatants were collected and cytokine protein 
secretion was quantified by ELISA assays for MIP-2 (A), TNF-α (B), GM-CSF (C), and IL-6 
(D). Error bars represent the SEM (n ≥ 5). Statistical significance between groups is represented 








The loss of the O antigen does not influence the inflammatory response elicited by the 
cellular outer membrane 
 We evaluated if changes to the OM resulting from O antigen loss would alter the 
inflammatory response.  The current study demonstrated that the loss of the O antigen and 
resulting changes to the OM did slightly alter the inflammatory response elicited by the K. 
pneumoniae OM. At the highest dose inflammatory cytokine gene expression was relatively 
similar for both wild type and ΔwbbO OM treatments (Figure 3.5). However, at the lower doses 
the ΔwbbO OM stimulates a moderately, but not significantly, stronger response than the wild 
OM. As seen in Figure 3.6, there are some minor variations in cytokine protein secretion, but 
these variations are not significant between the wild type and O antigen-deficient OM responses. 
While the protein content of the OM was altered by the loss of the O antigen the inflammatory 
response was not drastically altered by these changes. These data indicate that the absence of the 
O antigen does not impact the inflammatory response elicited by the K. pneumoniae cellular OM 










                        
 
                      
       
                       
Figure 3.5 O antigen-deficient K. pneumoniae outer membrane fractions elicit more potent 
inflammatory responses than wild type OM fractions. RAW 264.7 murine macrophages were 
treated with increasing doses of OM fractions derived from K. pneumoniae 43816 or ΔwbbO. 
Cells were incubated for 3 hr and gene expression was quantified by real-time PCR for MIP-2 
(A), TNF-α (B), GM-CSF (C), IL-1β (D), IL-6 (E), and iNOS (F). Error bars represent the SEM 









                       
 
 




Figure 3.6 O antigen-deficient K. pneumoniae OM stimulates a stronger responses than the wild 
type OM. RAW 264.7 murine macrophages were treated with different doses of OM fractions   
from K. pneumoniae 43816 and ΔwbbO. Cells were incubated for 3 hrs and the culture media 
supernatants were collected and cytokine protein secretion was quantified by ELISA assays for 
MIP-2 (A), TNF-α (B), GM-CSF (C), and IL-6 (D). Error bars represent the SEM (n ≥ 5). 







O antigen-deficient OMVs elicit a potent IL-6 response 
 The previously described proteomic analysis revealed that O antigen-deficient OMVs 
were significantly less abundant in outer membrane proteins and were enriched in chaperones 
compared to wild type vesicles. Therefore it is likely that the changes of the OMV protein 
components associated with O antigen loss will alter the OMV mediated inflammatory response. 
For most of the cytokines assayed in this study, there were no significant differences in wild type 
and O antigen-deficient OMV responses (Figure 3.7). At the lower doses, IL-6, iNOS, and IL-1β 
gene expression was increased in macrophages treated with ΔwbbO OMVs. However, 
significance was only seen for IL-6. IL-6 protein secretion was significantly elevated in 
macrophages treated with ΔwbbO OMVs rather than wild type OMVs (Figure 3.8). There was 
also a significant increase in GM-CSF protein levels due to O antigen-deficient OMV exposure. 
This study indicates that the changes in OMV protein composition due to O antigen loss produce 





                 
 




                           
                      
                      
Figure 3.7 O antigen-deficient K. pneumoniae outer membrane OMVs elicit a more potent 
inflammatory responses than wild type OMVs. RAW 264.7 murine macrophages were treated 
with increasing doses of OMVs derived from K. pneumoniae 43816 or ΔwbbO. Cells were 
incubated for 3 hr and gene expression was quantified by real-time PCR for MIP-2 (A), TNF-α 
(B), GM-CSF (C), IL-1β (D), IL-6 (E), and iNOS (F). Error bars represent the SEM (n ≥ 4). 
Statistical significance between groups is represented by horizontal brackets (* P < 0.05).  










                            
   
                     
Figure 3.8 O antigen-deficient K. pneumoniae OM stimulates a stronger IL-6 responses than the 
wild type OM. RAW 264.7 murine macrophages were treated with different doses of 
OMVspurified  from K. pneumoniae 43816 and ΔwbbO. Cells were incubated for 3 hrs and the 
culture media supernatants were collected and cytokine protein secretion was quantified by 
ELISA assays for MIP-2 (A), TNF-α (B), GM-CSF (C), and IL-6 (D). Error bars represent the 












 The purpose of the present study was to do a comparative analysis of the inflammatory 
responses elicited by the outer membrane (OM) and secreted outer membrane vesicles (OMVs) 
derived from wild type and O antigen-deficient (ΔwbbO) Klebsiella pneumoniae.  
 The previous chapter demonstrated that the protein content of the OM and OMV were 
significantly different from one another.  In the present study macrophages were exposed to OM 
fractions or purified OMVs derived from wild type and an O antigen mutant and the production 
of pro-inflammatory cytokines (IL-6, IL-1β, MIP-2, TNF-α, iNOS, and GM-CSF) were 
measured by Real-Time PCR and ELISA. When comparing the inflammatory responses 
stimulated by wild type OM components and the secreted OMVs, it was found that the OMVs 
rather than the cellular OM produced a significantly more potent inflammatory response. The 
previous proteomic study also concluded that the loss of the O antigen altered protein expression 
in both the OM and OMVs. Interestingly, the loss of the O antigen and resulting changes to the 
protein content of the membrane did not significantly impact the pattern of cytokine production 
in response to the OM but did alter the inflammatory responses elicited by the OMVs. 
 Because the protein content of OMVs is distinct from that of the cellular OM, it was 
anticipated that the inflammatory responses elicited by the OM and OMVs would also differ. 
Results from this study demonstrated that the OMVs produce a more powerful inflammatory 
response when compared to the OM. Even at the lowest dosage (0.0001 μg), both the transcript 
levels and protein products of inflammatory cytokine were significantly higher in response to 
OMV treatments. These data suggest that OMVs elicit a significantly stronger inflammatory 




This is the first study to directly compare the ability of the OM and OMV contents to 
stimulate the inflammatory response. Several in vivo studies support the conclusion that secreted 
OMVs rather than the cellular components stimulate a more potent immune response. Lee et 
al.(20120), reported that mice exposed to K. pneumoniae OMVs displayed more severe 
pathological changes in the lung than mice infected with live bacteria (30). Rat and mouse 
peritonitis models have analyzed the ability of OMVs to induce sepsis and also demonstrate the 
potent inflammatory response elicited by OMVs, most notably increased serum TNF-α and IL-6 
levels. These studies demonstrated that OMVs from Escherichia coli induced sepsis in the 
absence of the originating bacterial cell (73, 74). These data demonstrate that OMVs themselves 
are highly potent virulence factors that elicit a stronger inflammatory response than the cells 
from which they are derived.  
Both Lpp and OmpA are known to stimulate the production of inflammatory cytokines 
during K. pneumoniae infection and the enrichment of Lpp and OmpA likely contributes to the 
increased inflammatory response produced by K. pneumoniae OMVs (77, 78). The influence of 
outer membrane proteins should also be considered when evaluating these results since LPS and 
proteins are known to synergistically stimulate host immune responses.  Results of the previous 
chapter revealed that compared to OMVs, the OM samples were significantly less enriched in 
many outer membrane proteins such as OmpA and Lpp. It has been shown the Lpp contributes to 
K. pneumoniae in vivo virulence by enhancing bacterial dissemination and stimulating a potent 
IL-6 response (77). Additionally, K. pneumoniae OmpA has been implicated in the adherence 
and inflammatory response resulting from K. pneumoniae derived pneumonia (78).  As seen if 




difference is likely due to OMVs being highly enriched in protein such as Lpp and OmpA that 
are known stimulators of the inflammatory response in Gram-negative bacteria.  
 The loss of the O antigen significantly altered the protein composition of K. pneumoniae 
OMVs. From the previous study, we concluded the ΔwbbO OMVs were less enriched in outer 
membrane porins and were more abundant in chaperones, compared to wild type OMVs. From 
the previous proteomic study it would be anticipated that a decrease in outer membrane porins, 
such as OmpA and OmpK35, would ultimately decrease the inflammatory response. However, 
studies in other bacterial species indicate that O antigen loss allows better access to the exposed 
LPS lipid A and protein PAMPs on the cell surface. This increased exposure to surface PAMPs 
provides better access to immune receptors. Based on this premise, the absence of the O antigen 
should ultimately result in a stronger inflammatory response (36, 79). Therefore we predicted 
that the loss of the LPS O antigen would result in O antigen-deficient K. pneumoniae producing 
an altered inflammatory cytokine response when compared to the wild type strain. This alteration 
could be due to either an increased inflammatory response due to better access to the surface 
because of loss of the O antigen, or decreased inflammation due to the altered protein content of 
these OMVs. Figures 3.5 and 3.6 demonstrate that O antigen loss only resulted in minor 
variations in inflammatory cytokine production patterns produced from the OM. The OM 
fractions derived from ΔwbbO produced a slightly enhanced cytokine response compared to wild 
type OM fractions. The relationship observed between wild type and O antigen-deficient OM 
cytokine responses was similar to that of wild type and O antigen-deficient OMVs. This result 
suggests the effects of O-antigen loss and altered membrane composition may have a balancing 
effect on the ultimate inflammatory response. The vesicles from the O antigen mutant produced a 




differences in cytokine production observed between OMV treatments were not significantly 
different.  
 The role of the O antigen in K. pneumoniae immune response has been evaluated in other 
studies. A study by Shankar-Sinha et al. (2004), evaluated the effects of O antigen loss on K. 
pneumoniae in vivo pathogenicity. Mice intratracheally injected with live K. pneumoniae ΔwbbO 
bacteria had increased survival compared to mice injected with wild type cells (10). The O 
antigen mutant colonized lung tissue at the same rate as the wild type strain. However, the O 
antigen mutant failed to trigger bacteremia, which is identified by the presence of viable bacteria 
in the blood. If the localized inflammatory responses are potent, the tissue can be damaged, 
allowing for bacteria to enter the blood stream causing bacteremia. A failure to trigger 
bacteremia indicates that the O antigen mutant elicited a decreased inflammatory response. Our 
data differs from the in vivo study conducted by Shankar-Sinha et al. (2004) because our 
measured in vitro inflammatory response elicited by K. pneumoniae ΔwbbO was not attenuated, 
but rather indicates that the absence of the O antigen enhanced the inflammatory response in 
vitro. The findings of our study were supported by another in vitro study conducted by Evrard et 
al. (2010), in which whole UV killed K. pneumoniae wecA mutants deficient in O antigen were 
exposed to dendritic cells. In agreement with the findings of our study, Evrard et al. (2010), 
reported that the O antigen mutant generated  increased TNF-α and IL-12 expression in dendritic 
cells (2). The results of the current study and those reported by Evrard et al. (2010), indicate that 
the absence of the O antigen enhances the inflammatory response in vitro; however, the study 
performed by Shankar-Sinha et al. (2004), suggests that the absence of the O antigen does not 
enhance the inflammatory response. There are several factors that may explain discrepencies 




Evrard et al. (2010), respectively utilize OMVs and UV killed cells that are not actively 
replicating. It appears that the enhanced inflammatory response elicited by O antigen mutants in 
the in vitro studies may be associated with inactive bacterial components rather than live cells. 
Second, the in vivo study conducted by Shankar-Sinha et al. (2004) used live cells that were still 
capable of replicating and secreting cellular contents. This in vivo study exposed live bacterial 
cells to the complement system and multiple types of immune cells that negatively influence 
bacterial survival. Therefore, the findings reported by Shankar-Sinha et al. (2004), that the O 
antigen mutant failed to produce bacteremia may not be caused by a decreased inflammatory 
response, but could be due to the fact that the O antigen is required for resistance to complement 
mediated killing which results in decreased bacterial survival in vivo (5, 10).    
 Compared to wild type OMVs, ΔwbbO OMVs had a stronger inflammatory response and 
produced significantly higher IL-6 transcript and proteins levels. IL-6 is an inflammatory 
cytokine associated with Gram-negative bacterial infections. This cytokine is involved in the 
activation of the innate and adaptive immune responses by stimulating hepatocytes to produce 
acute-phase proteins involved in complement and by promoting the maturation of B cells. IL-6 
activation is important for priming the immune response and increased serum IL-6 is often 
associated with strong inflammatory responses that induce fever, tissue damage at the site of 
infection, and the progression to sepsis (73, 80).  Therefore, the association between the absence 
of the O antigen and increased IL-6 levels indicate that O antigen-deficient OMVs could greatly 
contribute to a potent inflammatory response elicited by K. pneumoniae.  A study conducted by 
Odenbreit et. al. (2006), evaluated the role of the O antigen in the ability of Helicobacter pylori 
to induce IL-6 protein production. Results of that study indicate that the absence of the O antigen 




agree with the findings of the present study.  One explanation for this discrepancy is the fact that 
H. pylori has a Lipid A structure that greatly differs from the endotoxic Lipid A structure found 
in K. pneumoniae and other enteric bacteria. Both E. coli and K. pneumoniae have a Lipid A 
structure consisting of a bisphosphorylated sugar backbone containing hexa-acylated fatty acid 
chains that are 12-14 carbons long (6). Deviations from this structure, such as underacylation, 
longer acyl chains, and underphosphorylation tend to reduce LPS endotoxicity (6). H. pylori LPS 
is typically less endotoxic because it is monophosporylated, has longer acyl chains (14-16 
carbons), and is underacylated (6). Compared to enteric LPS, Limulus amoebocyte lysate (LAL) 
assays revealed that H. pylori LPS has reduced endotoxicity by 100-500 fold. The absence of the 
O antigen may make the Lipid A portion more accessible for CD14 and TLR4, however, the H. 
pylori Lipid A structure tends to produce a much less potent inflammatory response than K. 
pneumoniae LPS. Other discrepancies between K. pneumoniae and H. pylori O antigen mutants’ 
abilities to induce IL-6 is likely because the outer membrane content is different between the two 
species. Furthermore, the current study utilized K. pneumoniae OMVs rather than whole cells, as 
were used in the H. pylori study. Given that the protein content of the outer membrane tends to 
be different from the protein content of OMVs, it is difficult to directly compare the OMVs used 
in this study to the whole cells used by Odenbreit et al. (2006). 
 The absence of the O antigen may not be the causative factor resulting in IL-6 up-
regulation and increased protein production. Several studies have demonstrated that GroEL 
(Hsp60), which was the most abundant protein identified in ΔwbbO OMVs, is present on the 
bacterial cell surface and stimulates the inflammatory response by interacting with LOX-1 on 
macrophages (40, 48). The presence of GroEL of the surface of H. pylori was also reported in the 




phagocytic IL-6 response elicited by Helicobacter pylori (69). The conclusion of the study 
conducted by Odenbreit et al. (2006), was that the presence of GroEL in the H. pylori OM was 
required for phagocytosis and IL-6 induction (69).  Other chaperone proteins could possibly 
contribute to inflammation and virulence in K. pneumoniae, such as chaperones DegP, which 
was also highly enriched in ΔwbbO OMVs. It has been demonstrated that K. pneumoniae DegP 
mutants had higher LD50 doses in mouse models indicating that DegP contributes to in vivo 
virulence (81). Therefore, the absence of the O antigen may not directly influence the increased 
IL-6 response, but rather indirectly influence the inflammatory response by altering the protein 
content of OMVs. 
 This is the first study to directly compare the inflammatory response elicited by the 
cellular outer membrane components to those of the secreted OMVs. We have demonstrated that 
OMVs elicit a more potent inflammatory response than the purified cellular OM components. 
Moderate inflammatory responses are beneficial to the host by recruiting immune cells to the site 
of infection and priming the adaptive immune response (6). However, severe inflammatory 
responses can result in a systemic reaction that can lead to septic shock, organ failure, and death. 
The ability of OMVs to stimulate a potent inflammatory response indicates that OMVs play a 
significant role in K. pneumoniae pathogenicity. Shedding of LPS from K. pneumoniae has been 
shown to be required to induce cytotoxicity in airway epithelial cells (82). This shedding is most 
likely via OMV secretion. Most studies evaluating the role of the O antigen in immune responses 
use purified LPS, as opposed to LPS in its native, outer membrane integrated form (OMVs) to 
evaluate the role of the O antigen in activating the inflammatory response.  Although absence of 
the O antigen from OMVs caused a slightly enhanced inflammatory response, these differences 




deficient OMVs cannot be directly attributed to the absence of the O antigen since other factors 
such as outer membrane proteins and chaperone enrichment were also altered in the O antigen 
mutant. Because there were alterations to both the proteins and LPS, we cannot solely confirm 










































 This study was designed to evaluate the protein composition of the cellular outer 
membrane (OM) with that of the secreted outer membrane vesicles (OMVs) of Klebsiella 
pneumoniae. It was hypothesized that the protein composition of the secreted OMVs would be 
significantly different than the protein composition of the cellular OM. The inflammatory 
responses elicited by the OM and OMVs were also evaluated in this study. It was also 
anticipated that the OMVs would produce a distinct inflammatory response, most likely a 
stronger response, compared to the response of the OM. In the current study, the effects of the 
lipopolysaccharide (LPS) O antigen loss on protein composition and inflammatory responses of 
the OM and OMVs were also evaluated. Here it was predicted that the absence of the O antigen 
from the outer membrane would further alter the protein composition of both the cellular OM 
and the secreted OMVs. Furthermore, the changes to the membrane associated with O antigen 
loss would result in O antigen-deficient OM fractions and OMVs that would generate an altered 
inflammatory response, compared to the respective wild type OM and OMV responses.  
 Results of this study support the hypothesis that the OM and OMV sub-proteomes are 
significantly different. In this study, we found that there were many proteins that were either 
enriched in the OM or the OMVs, producing distinct OM and OMV protein profiles. This 
conclusion has been supported by several studies evaluating the protein profiles of the OM and 
OMVs by gel electrophoresis (25, 26). However, these studies only visualized the protein 




the OMV protein content. In order to elucidate the membrane components involved in the 
selective sorting mechanism found in OMVs, more proteomics studies analyzing both the OM 
and OMV derived from multiple species of Gram-negative bacteria are needed. 
  Comparative proteomics-based OMV analyses are lacking in general, especially for K. 
pneumoniae. A study conducted by Lee et al. (2012), provided a small OMV protein dataset 
consisting of only 159 proteins and lacked functional explanations for these proteins with regards 
to K. pneumoniae survival and pathogenicity. With the exception of this limited proteomic study 
conducted by Lee et al. (2012), there is little information about the protein composition of K. 
pneumoniae OMVs Lee, et al. (30). Therefore more OM and OMV proteomic based studies 
using different K. pneumoniae strains are needed to fully understand the components and 
functionality of the membrane protein content.  
 Knowing that the OMVs have a dissimilar protein profile to the OM, it was anticipated 
that the OMVs would also produce an altered inflammatory response. Our study demonstrated 
that OMVs produce a much more potent inflammatory response than the cellular OM. The 
findings of our study have been supported by several studies reporting that OMVs stimulate a 
more potent inflammatory response than whole cells in in vivo (73, 74). The current study 
utilized purified OM fractions that form spheroplasts which structurally resemble vesicles. By 
using OM spheroplasts, we were able to directly compare the cellular OM and secreted OMV 
responses void of most of the intracellular components. However, this study did not identify the 
specific components responsible for the differences observed between the OM and OMV 
inflammatory responses. The next step for this study would be to evaluate the role of proteins 
that were highly enriched in OMVs in the inflammatory response. Comparing the OM and OMV 




such as OmpA or Lpp, would provide the detail needed to confirm which protein components are 
responsible for the potent OMV-mediated inflammatory response.  
 A secondary goal of this study was to evaluate the effect of O antigen loss on the protein 
composition of the OM and OMVs. It was predicted that the OM and OMVs derived from O 
antigen-deficient K. pneumoniae would have an altered protein profile, compared to the wild 
type strain. From our study we concluded that the absence of the O antigen slightly alters the 
protein content of the OM. However O antigen loss significantly altered the protein content of 
the OMVs. This trend has also been demonstrated in P. gingivalis and P. aeruginosa. These 
studies confirm our findings that while the OM protein content was not significantly changed by 
O antigen loss, the protein cargo of OMVs were significantly altered by the loss of the O antigen 
(25, 26). It is currently hypothesized that the selective sorting mechanism found in OMVs may 
be further altered by LPS modifications (23, 29). This hypothesis was formed based on data 
obtained analyzing bacterial species that contain negatively charged O antigen sugar residues. 
However, in K. pneumoniae LPS, the negative charge is imparted by galacturonic acid (GalU) 
residues on the core oligosaccharide (61). In order to confirm that the negative charge on the 
LPS influences protein integration into OMVs, the core oligosaccharide containing the GalU 
residues would need to be removed in K. pneumoniae. Repeating the proteomic study with a K. 
pneumoniae WabH mutant lacking charged GalU residues would provide the data needed to 
confirm that charged LPS influences protein packing into OMVs.  
Given that O antigen-deficient OMVs having a significantly different protein profile than wild 
type OMVs, it was hypothesized that the inflammatory response would also be altered by the 
absence of the O antigen in OMVs. O antigen-deficient OMVs did have an altered inflammatory 




stimulate the inflammatory response. Therefore, it is difficult to discern whether the loss of the O 
antigen directly influences inflammatory responses by providing TLRs with easier access to 
outer membrane PAMPs or indirectly influences the inflammatory response by altering the 
abundance of protein PAMPs. For instance, O antigen-deficient OMVs were highly enriched in 
GroEL and DegP compared to wild type OMVs. Other studies have reported that GroEL has 
been implicated in the activation of the inflammatory response (69). DegP has been associated 
with K. pneumoniae survival during infection (81). The enrichment of these proteins in O 
antigen-deficient OMVs could likely be responsible for the increased inflammatory response 
compared to wild type OMVs. Re-evaluating the inflammatory response after knocking out these 
proteins in the O antigen mutant would clarify if the proteins themselves or the absence of the O 
antigen causes O antigen-deficient OMVs to produce an increased inflammatory response.  
 In conclusion, this study was able to demonstrate that the OM and OMVs have 
significantly different protein profiles. This difference in protein profiles is likely responsible for 
the difference in the OM- and OMV-mediated inflammatory responses. The findings of this 
study also indicate that the loss of the O antigen significantly alters the protein content and 
inflammatory response elicited by OMVs. While this study provides a solid backbone for 
analyzing the protein content and inflammatory responses of the cellular OM and secreted 
OMVs in K. pneumoniae, future studies are needed to further elucidate the components of K. 
pneumoniae membrane and how they relate to the inflammatory response. Future studies could 
confirm the findings of this in vitro study by performing in vivo virulence studies using a mouse 
model. These future immunological studies should also compare the OM and OMVs to both live 
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ΔwbbO OM ΔwbbO OMV 43816 OM 43816 OMV
Cell division protein FtsZ ftsZ R4Y5E6 40 kDa Cyt D 1.68 2.52 2.21 0.50
Chromosome partition protein MukB mukB R4YCA4 170 kDa Cyt D 0.79 0.00 2.85 0.50
Site-determining protein minD G0GIL6 30 kDa Cyt D 3.02 4.30 2.02 0.50
MglB protein mglB R4YDJ2 35 kDa PP G 4.78 0.56 5.08 0.00
OmpA protein ompA ompA R4YB96 41 kDa OM M 51.12 60.23 15.61 108.73
OmpK17  (OmpX) ompk17 Q48427 18 kDa OM M 19.09 15.44 7.71 28.40
OmpC protein ompC R4Y807 41 kDa OM M 7.81 34.83 3.64 48.50
Outer membrane lipoprotein SlyB slyB G0GU11 15 kDa OM M 5.31 18.23 3.69 29.69
Tsx protein tsx R4YEE4 33 kDa OM M 3.89 13.61 3.71 23.73
TolC protein tolC R4YHT0 53 kDa OM M 7.35 3.08 5.04 10.89
Outer membrane protein assembly factor BamA yaeT R4Y5W4 90 kDa OM M 4.40 4.27 4.37 3.47
NlpD protein nlpD R4YHC8 40 kDa OM M 2.37 6.02 2.21 21.35
UTP--glucose-1-phosphate uridylyltransferase subunit GalU galU G0GHM2 33 kDa Cyt M 4.64 11.89 2.18 3.27
LPS-assembly protein LptD lptD R4YBZ4 85 kDa OM M 4.39 0.56 4.54 2.48
Scaffolding protein for murein-synthesising holoenzyme mipA G0GL03 28 kDa OM M 2.02 12.87 0.67 29.20
OmpW protein ompW R4YFW6 23 kDa OM M 4.21 3.02 3.02 1.29
Putative outer membrane lipoprotein KPN2242_22575 G0GN82 22 kDa OM M 2.23 6.07 1.50 4.46
UDP-glucose pyrophosphorylase galF A2V7R3 33 kDa Cyt M 1.68 5.04 2.35 0.50
Penicillin-binding protein activator LpoA lpoA R4YEQ9 77 kDa OM M 0.87 3.61 0.34 2.28
OmpF protein ompK35 O87753 40 kDa OM M 2.42 4.49 0.17 15.00
ABC transporter outer membrane lipoprotein vacJ G0GNY0 28 kDa OM M 0.87 3.05 1.18 5.36
OmpA protein ompA ompA R4YB97 41 kDa OM M 1.35 1.11 1.70 0.00
60 kDa chaperonin groEL groEL G0GGA7 57 kDa Cyt O 99.03 102.02 45.30 39.78
Chaperone protein DnaK dnaK R4Y5P6 68 kDa Cyt O 12.54 26.48 13.46 13.37
FKBP-type peptidyl-prolyl cis-trans isomeraseTrigger factor tig R4YHL8 48 kDa Cyt O 12.76 13.21 9.44 9.60
Heat shock protein 90 htpG G0GQB6 71 kDa Cyt O 4.28 9.98 4.71 4.27
ClpB protein clpB R4Y6I5 96 kDa Cyt O 3.09 2.97 2.86 0.00
Alkyl hydroperoxide reductase subunit C ahpC G0GT45 21 kDa Cyt O 7.21 2.31 8.06 3.54
Lon protease lon R4YEB6 89 kDa Cyt O 1.24 2.63 3.21 0.00
DegP protein degP R4Y5J4 50 kDa PP O 1.68 7.96 2.50 5.75
alkyl hydroperoxide reductase subunit C KPR_4367 R4YIQ4 22 kDa Cyt O 4.76 1.19 5.06 0.00
Co-chaperonin GroES groES1 G0GGA6 10 kDa Cyt O 14.11 0.00 5.20 2.58
peptidyl-prolyl cis-trans isomerase ybaU R4YHL6 68 kDa PP O 1.18 0.56 2.18 1.49
FtsH protease regulator HflK hflK G0GGE4 46 kDa IM O 1.06 1.30 1.16 5.06
Peptidyl-prolyl cis-trans isomerase KPR_0740 R4YBB0 23 kDa PP O 2.62 3.05 2.19 5.33
Stringent starvation protein A sspA G0GJQ5 24 kDa Cyt O 0.37 0.00 4.22 0.00
ATP-dependent protease ATPase subunit HslU hslU G0GRU2 50 kDa Cyt O 1.56 4.41 1.16 4.54
61 kDa chaperonin groEL groEL G0GGA8 57 kDa Cyt O 1.16 0.00 2.85 0.00
PrkA family serine protein kinase KPR_2238 R4Y8E4 74 kDa Cyt T 1.48 0.56 2.20 0.00
Protein-export protein SecB secB G0GND1 17 kDa Cyt U 5.25 1.83 7.59 1.29
Protein translocase subunit SecA secA R4YC49 102 kDa Cyt U 1.77 0.00 1.83 0.00
AcrB protein acrB R4YE63 98 kDa IM V 1.68 1.11 2.03 0.99
Cellular Process & Signaling
Supplmental Table S1:  The normalized spectral sums, cellular localization, and COG functional classification for the top 200 most abundant proteins across all
samples identified in Klebsiella pneumoniae 43816 and ΔwbbO outer membrane (OM) and outer membrane vesicles (OMV).  COG category descriptions are listed at











ΔwbbO OM ΔwbbO OMV 43816 OM 43816 OM
Elongation factor Tu ef-tu ef-TU G0GKM4 43 kDa Cyt J 51.11 66.86 37.38 75.81
Elongation factor G fusA fusA G0GKM5 78 kDa Cyt J 26.76 13.23 19.93 6.62
30S rib rpsA R4YGT0 61 kDa Cyt J 20.29 15.04 14.63 28.17
50S rib rplB G0GKL6 30 kDa Cyt J 5.83 23.22 3.52 12.41
30S rib rpsD G0GKJ6 24 kDa Cyt J 4.60 16.13 4.90 13.67
Elongation factor Ts tsf R4Y9M1 31 kDa Cyt J 10.88 1.19 8.40 0.00
30S rib rpsC G0GKL3 26 kDa Cyt J 7.04 18.09 3.71 10.09
50S rib rplL R4Y4G6 12 kDa Cyt J 7.92 8.09 8.74 8.91
Translation initiation factor IF-2 infB G0GJK5 98 kDa Cyt J 7.68 4.16 5.05 0.00
50S rib rplC G0GKL9 22 kDa Cyt J 12.41 10.80 2.03 1.98
30S rib rpsE G0GKK2 18 kDa Cyt J 5.62 13.56 3.37 4.57
30S rib rpsB G0GLU3 27 kDa Cyt J 5.51 11.39 5.90 4.27
50S rib rplF G0GKK4 19 kDa Cyt J 5.41 6.63 4.19 8.11
50S ribosomal protein rplQ G0GKJ4 14 kDa Cyt J 1.12 8.12 0.67 5.56
50S ribosomal protein L15 rplO G0GKK0 15 kDa Cyt J 5.92 7.70 3.00 12.38
Polyribonucleotide nucleotidyltransferase pnp R4YIY4 76 kDa Cyt J 6.08 3.34 4.88 0.00
30S ribosomal protein S9 rpsI G0GJQ6 15 kDa Cyt J 4.26 4.88 2.52 5.56
50S ribosomal protein L14 rplN G0GKK9 14 kDa Cyt J 3.23 4.49 3.88 5.56
Glycine--tRNA ligase beta subunit glyS R4YFI7 76 kDa Cyt J 2.60 2.78 4.50 0.00
50S ribosomal protein L21 rplU G0GJM3 12 kDa Cyt J 8.77 5.71 2.50 9.87
30S ribosomal protein S10 rpsJ G0GKM0 12 kDa Cyt J 2.47 9.53 2.35 7.02
Aspartate--tRNA ligase aspS G0GJG6 66 kDa Cyt J 3.64 1.19 5.02 0.00
50S ribosomal protein L13 rplM R4YIZ5 19 kDa Cyt J 2.99 3.05 3.19 2.78
Alanine--tRNA ligase alaS R4Y667 96 kDa Cyt J 3.97 0.00 3.53 0.00
50S ribosomal protein L18 rplR G0GKK3 13 kDa Cyt J 3.04 9.28 0.51 12.68
Leucine--tRNA ligase leuS R4YH52 97 kDa Cyt J 2.10 0.56 3.53 0.00
Lysine--tRNA ligase lysS G0GV85 58 kDa Cyt J 1.72 2.41 3.72 0.00
50S ribosomal protein L22 rplV G0GKL4 12 kDa Cyt J 3.16 5.68 2.00 16.08
50S ribosomal protein L4 rplD R4Y5C4 22 kDa Cyt J 4.10 6.18 2.52 0.99
50S ribosomal protein L9 rplI G0GH43 16 kDa Cyt J 6.16 3.74 2.87 5.33
Isoleucine--tRNA ligase ileS R4Y983 103 kDa Cyt J 2.77 0.00 3.86 0.00
50S ribosomal protein L10 rplJ G0GSV3 18 kDa Cyt J 4.18 7.54 1.70 0.00
Ribonuclease E rne R4Y882 119 kDa Cyt J 4.76 1.11 3.66 0.00
50S ribosomal protein L5 rplE G0GKK7 20 kDa Cyt J 3.62 4.83 2.89 2.28
30S ribosomal protein S7 rpsG G0GKM6 18 kDa Cyt J 2.10 8.04 2.34 4.57
50S ribosomal L23 rplW G0GKL7 11 kDa Cyt J 1.81 3.79 0.51 7.61
30S ribosomal protein S6 rpsF R4YAT3 15 kDa Cyt J 3.81 4.83 1.36 0.00
Valine--tRNA ligase valS R4YAZ9 108 kDa Cyt J 0.19 0.00 1.84 0.00
30S ribosomal protein S13 rpsM G0GKJ8 13 kDa Cyt J 1.54 3.02 2.36 0.00
Glutathione synthetase gshB G0GGZ6 35 kDa Cyt J 3.32 0.00 3.03 0.00
Elongation factor Tu ef-tu ef-TU G0GKM5 43 kDa Cyt J 4.20 0.66 1.68 0.99
DNA-directed RNA polymerase rpoC G0GSV6 155 kDa Cyt K 10.51 14.67 11.08 3.27
DNA-directed RNA polymerase subunit beta rpoB R4Y490 152 kDa Cyt K 9.45 12.57 12.56 4.76
DNA-directed RNA polymerase subunit alpha rpoA G0GKJ5 36 kDa Cyt K 6.05 10.14 6.08 9.40
PutA protein putA R4YBC6 145 kDa Cyt K 2.28 0.64 5.17 0.00
Transcription termination factor Rho rho R4Y7C7 50 kDa Cyt K 3.97 1.88 3.21 4.84
Transcription termination/antitermination protein NusA nusA G0GJK6 55 kDa Cyt K 4.09 1.22 3.19 0.50
Recombinase A recA G0GRR9 38 kDa Cyt L 0.56 11.67 0.66 2.78
DNA gyrase subunit B gyrB R4Y6T5 90 kDa Cyt L 0.37 0.64 1.84 0.00
HrpA protein hrpA R4Y9R0 149 kDa Cyt L 0.37 0.66 0.33 3.54
DNA gyrase subunit A gyrA R4Y7H5 97 kDa Cyt L 1.35 0.56 2.01 0.00











ΔwbbO OM ΔwbbO OMV 43816 OM 43816 OM
PflB protein formate acetyltransferase pflB pflB R4YCC3 85 kDa Cyt C 12.24 13.58 19.35 4.04
ATP synthase subunit beta atpB atpB G0GQ84 50 kDa IM C 15.52 22.18 16.67 7.81
AceF protein aceF R4Y5U7 66 kDa Cyt C 10.06 33.73 5.65 43.70
ATP synthase subunit alpha atpA G0GQ86 55 kDa IM C 12.31 23.45 13.62 11.09
Aldehyde-alcohol dehydrogenase adhE R4YFG8 96 kDa Cyt C 12.13 9.74 16.46 0.99
Pyruvate dehydrogenase E1 component aceE R4Y5F9 99 kDa Cyt C 12.30 4.99 13.92 0.99
Dihydrolipoyl dehydrogenase lpdA R4Y9G6 51 kDa Cyt C 6.51 23.32 5.70 9.03
NarG protein narG R4YB12 141 kDa IM C 2.71 5.52 5.70 10.32
Succinyl-CoA ligase [ADP-forming] subunit beta sucC R4YCF4 42 kDa Cyt C 7.22 8.57 7.09 4.27
Dihydrolipoamide succinyltransferase sucB G0GTX2 44 kDa Cyt C 3.81 9.76 7.07 2.28
Aconitate hydratase 2 acnB R4Y5U9 94 kDa Cyt C 4.69 3.42 6.88 0.99
Isocitrate dehydrogenase [NADP] icdA F1DFL4 46 kDa Cyt C 7.64 1.11 6.05 1.29
SucA protein sucA R4YH31 105 kDa Cyt C 6.62 4.05 5.84 0.00
Succinate dehydrogenase, flavoprotein subunit sdhA R4YD02 63 kDa IM C 3.87 13.05 4.04 3.97
Malate dehydrogenase mdh R4YIZ6 32 kDa Cyt C 8.90 0.56 5.94 0.00
Succinyl-CoA ligase [ADP-forming] subunit alpha sucD G0GUL4 30 kDa Cyt C 3.76 1.67 4.18 11.46
Aldehyde dehydrogenase (NAD) family protein KPR_1299 R4YA65 55 kDa Cyt C 6.56 0.00 6.14 0.00
Glycerol kinase glpK R4Y4P0 56 kDa Cyt C 2.53 2.39 5.08 1.49
ATP synthase subunit b atpF G0GQX5 17 kDa IM C 4.35 6.24 2.16 5.45
ATP synthase gamma chain atpG G0GQ85 32 kDa Cyt C 1.43 0.00 3.90 0.00
Citrate synthase cisY R4YH33 48 kDa Cyt C 3.43 0.00 4.69 0.00
CydA protein cydA R4YI62 58 kDa IM C 5.18 3.61 3.04 1.49
Phosphoenolpyruvate carboxykinase pckA R4YFN7 58 kDa Cyt C 2.31 1.11 3.37 0.00
fumarate reductase flavoprotein subunit frdA R4Y4K6 65 kDa Cyt C 1.87 1.22 3.21 0.50
Inorganic pyrophosphatase ppa G0GH67 20 kDa Cyt C 5.59 3.61 1.69 0.00
MmsA protein mmsA R4Y4S8 54 kDa Cyt C 1.62 0.00 3.01 0.00
NarH protein narH R4YAC3 58 kDa IM C 1.16 0.66 2.52 5.06
NuoG protein nuoG R4Y7F5 100 kDa Cyt C 1.39 0.56 2.33 0.00
NADH-quinone oxidoreductase subunit C/D nuoCD G0GN40 69 kDa IM C 1.06 0.66 3.20 0.99
PutA protein putA R4YBC6 145 kDa Cyt E 2.28 0.64 5.17 0.00
Urocanate hydratase hutU R4YCT2 62 kDa Cyt E 7.55 2.47 8.09 0.00
Histidine ammonia-lyase hutH R4YI45 53 kDa Cyt E 7.37 1.11 7.73 0.00
putative lysine decarboxylase KPR_4061 R4YHB3 82 kDa Cyt E 4.34 0.00 6.01 0.00
Aspartate ammonia-lyase aspA G0GGA2 52 kDa Cyt E 3.87 0.56 5.38 0.00
Serine hydroxymethyltransferase glyA R4Y647 45 kDa Cyt E 1.62 1.22 3.70 0.99
OppA protein oppA R4YAA5 61 kDa PP E 1.91 0.00 5.22 0.00
Glycine dehydrogenase [decarboxylating] gcvP R4YEZ3 101 kDa Cyt E 0.93 0.00 4.00 0.00
PepD protein pepD R4Y600 52 kDa Cyt E 0.87 0.00 3.36 0.50
D-amino acid dehydrogenase small subunit dadA R4YB55 47 kDa IM E 1.24 1.30 2.03 1.79
30S ribosomal protein S11 rpsK G0GKJ7 14 kDa Cyt E 2.52 3.71 1.18 5.86
Cysteine synthase cysK Q0ZB89 35 kDa Cyt E 2.29 0.56 2.53 0.00
AspC protein aspC R4YBN3 43 kDa Cyt E 2.31 1.67 3.73 0.00
Ribose-phosphate pyrophosphokinase prsA R4YFK8 34 kDa Cyt E/F 2.08 3.61 2.52 0.50
Purine nucleoside phosphorylase DeoD-type deoD R4Y5N1 26 kDa Cyt F 4.55 1.22 3.39 0.00
Inosine-5'-monophosphate dehydrogenase guaB G0GPX1 52 kDa Cyt F 3.45 0.56 4.87 0.50
Ribonucleoside-diphosphate reductase nrdA R4YF73 86 kDa Cyt F 2.35 2.52 2.36 0.50
Adenylosuccinate synthetase purA G0GGE8 47 kDa Cyt F 1.87 1.11 3.05 0.00
Uridylate kinase pyrH G0GMI7 26 kDa Cyt F 0.81 0.00 1.52 0.00
CTP synthase pyrG G0GTD7 60 kDa Cyt F 1.24 1.30 2.33 0.00
Glyceraldehyde-3-phosphate dehydrogenase A gapA G0GL06 35 kDa Cyt G 53.91 31.35 19.88 24.13
Enolase enoj R4YIH7 46 kDa Cyt G 17.52 22.36 15.21 7.81
Metabolism Spectral Abundance
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Phosphoglycerate kinase pgk G0GGY4 41 kDa Cyt G 9.60 5.72 16.09 0.00
FbaA protein fbaA R4YF09 37 kDa Cyt G 15.27 3.53 11.27 0.00
Phosphoenolpyruvate synthase ppsA R4Y9N4 87 kDa Cyt G 5.05 4.85 6.72 1.29
Pyruvate kinase pykF R4Y9K5 51 kDa Cyt G 5.71 1.67 7.94 1.29
Transketolase tktA R4Y8C3 72 kDa Cyt G 4.89 3.61 7.39 1.29
Aconitase acnA R4Y890 98 kDa Cyt G 4.69 1.30 5.90 1.29
6-phosphogluconate dehydrogenase, decarboxylating gnd G0LD05 51 kDa Cyt G 4.85 3.50 6.86 0.00
Transaldolase talB R4Y5A8 35 kDa Cyt G 4.53 0.56 6.39 0.00
Pyruvate kinase pykA R4YAU5 51 kDa Cyt G 3.93 5.38 3.90 1.79
Phosphoenolpyruvate-protein phosphotransferase ptsI R4Y7Q8 63 kDa Cyt G 4.18 2.52 5.06 4.54
Phosphoglyceromutase gpmA G0GUN2 28 kDa Cyt G 8.78 1.75 4.73 2.58
Glucose-6-phosphate isomerase pgi R4Y4E6 61 kDa Cyt G 2.86 0.64 3.69 0.00
FbaB protein fbaB R4YDN3 38 kDa Cyt G 4.66 1.19 4.56 0.00
Triosephosphate isomerase tpiA G0GP66 27 kDa Cyt G 4.90 0.00 3.40 3.54
ScrY protein scrY R4YDP8 56 kDa OM G 1.71 2.52 1.69 6.25
Pgm protein pgm R4YD15 57 kDa Cyt G 3.49 0.56 3.85 0.00
Putative myo-inositol catabolism protein KPN2242_01460 G0GI16 71 kDa Cyt G 1.43 0.56 4.07 0.00
Klebsiella pneumoniae subsp. rhin KPR_2139 R4Y7M6 51 kDa IM G 0.87 4.27 3.16 6.32
Crr protein crr R4YEV8 18 kDa Cyt G 2.91 1.86 2.88 1.79
Phosphopentomutase deoB G0GJW3 44 kDa Cyt G 2.47 0.00 3.73 0.00
MalE protein malE R4Y4F1 41 kDa PP G 1.31 0.00 2.69 0.00
2,3-bisphosphoglycerate-independent phosphoglycerate mutase gpmI R4YFY9 56 kDa Cyt G 1.54 0.00 2.56 0.00
6-phosphofructokinase pfkA R4Y9P2 35 kDa Cyt G 1.56 0.00 2.37 0.00
Glyceraldehyde-3-phosphate dehydrogenase A gapA G0GL07 35 kDa Cyt G 3.29 1.11 2.52 0.00
Glutathione synthetase gshB G0GGZ6 35 kDa Cyt H 3.32 0.00 3.03 0.00
Vitamin B12 transporter BtuB btuB R4Y432 68 kDa OM H 0.00 3.61 0.67 13.34
S-adenosylmethionine synthase metK R4YFG0 42 kDa Cyt H 2.95 0.56 2.70 0.00
HemX protein hemX R4Y7E1 43 kDa OM H 1.86 3.55 1.69 0.99
Carbamoyl-phosphate synthase large chain carB R4Y993 118 kDa Cyt I 1.54 1.83 2.65 0.00
FabB protein fabB R4Y7C9 38 kDa Cyt I 2.10 6.34 2.03 5.33
Acetyl-coenzyme A synthetase acs G0GUJ0 72 kDa Cyt I 2.24 0.56 3.87 0.00
PflB protein formate acetyltransferase pflB pflB R4YCC4 85 kDa Cyt C 2.89 -0.24 2.70 0.38
PflB protein formate acetyltransferase pflB pflB R4YCC4 85 kDa Cyt C 2.83 -0.35 2.64 0.32
ATP synthase subunit beta atpB atpB G0GQ85 50 kDa IM C 2.78 -0.45 2.57 0.27
AceF protein aceF R4Y5U8 66 kDa Cyt C 2.73 -0.56 2.51 0.21
ATP synthase subunit alpha atpA G0GQ87 55 kDa IM C 2.68 -0.66 2.45 0.16
Aldehyde-alcohol dehydrogenase adhE R4YFG9 96 kDa Cyt C 2.63 -0.77 2.38 0.10











ΔwbbO OM ΔwbbO OMV 43816 OM 43816 OM
Murein lipoprotein KPN2242_ KPN2242_13630 G0GGR8 8 kDa OM * 12.51 57.83 5.89 122.11
Klebsiella pneumoniae subsp. rhin KPR_1266 R4Y671 12 kDa PP * 2.00 15.17 1.68 13.26
Murein lipoprotein KPN2242_ KPN2242_13631 G0GGR9 8 kDa OM * 0.19 0.66 0.00 0.00
ABC transporter substrate binding protein KPR_2917 R4YH39 70 kDa Cyt R 11.63 0.66 8.31 0.00
Outer membrane lipoprotein yraP G0GIV4 20 kDa OM R 1.92 19.02 1.69 24.81
ATP-binding cassette domain of elongation factor 3 KPR_0924 R4Y955 62 kDa Cyt R 4.54 3.19 4.03 0.00
Global DNA-binding transcriptional dual regulator H-NS hns G0GHM1 15 kDa Cyt R 3.76 4.83 4.21 0.50
NAD(P)H dehydrogenase (quinone) wrbA R4YC37 21 kDa Cyt R 3.40 0.00 6.25 0.00
Uncharacterized protein yqjD G0GIT3 11 kDa Unknown S 4.26 8.04 3.36 2.28
YfaZ protein yfaZ R4Y5J6 19 kDa OM S 0.81 7.88 0.84 20.79
Outer membrane protein assembly factor BamB yfgL G0GPX6 42 kDa OM S 2.52 3.71 2.18 4.96
Outer membrane protein assembly factor BamC bamC R4Y768 37 kDa OM S 1.74 0.56 3.70 1.49
YbaY protein ybaY R4YCW8 15 kDa OM S 1.68 2.47 2.36 3.27
D Cell cycle control, cell division, chromosome partitioning
M Cell wall/membrane/envelope biogenesis
O Post-translation modification, protein turnover, chaperones
T Signal Transduction mechanisms
U Intracellular trafficking, secretion, and vesicular transport
V Defense mechanism
J Translation, ribosomal structure and biogenesis
K Transcription
L Replication, Recombination and repair
C Energy production and conversion
E Amino acid transport and metabolism
F Nucleotide transport and metabolism
G Carbohydrate metabolism and transport
H Coenzyme transport and metabolism
I Lipid transport and metabolism
P Inorganic ion transport and metabolism
* Not in COG genes




















Δwbb O 43816 OM-OM OMV-OMV
OmpA protein ompA ompA R4YB96 41 kDa OM M 0.76043643 0.001567519 0.239160262 0.040799283
Murein lipoprotein KPN2242_ KPN2242_13630 G0GGR8 8 kDa OM * 0.059886196 0.003423883 0.112310133 0.064297019
OmpK17  (OmpX) ompk17 Q48427 18 kDa OM M 0.751602804 0.002886961 0.336827721 0.035396224
OmpC protein ompC R4Y807 41 kDa OM M 0.166428173 0.075595115 0.279751268 0.606100641
Outer membrane lipoprotein SlyB slyB G0GU11 15 kDa OM M 0.023756437 0.002450687 0.163487071 0.091972113
Tsx protein tsx R4YEE4 33 kDa OM M 0.006090545 0.013556267 0.770990195 0.116109575
TolC protein tolC R4YHT0 53 kDa OM M 0.076491238 0.003378913 0.290881701 0.000403276
Outer membrane lipoprotein yraP G0GIV4 20 kDa OM R 0.033299327 0.136541449 0.689569758 0.691006843
Outer membrane protein assembly factor BamA yaeT R4Y5W4 90 kDa OM M 0.932369383 0.809913978 0.982941434 0.830103581
NlpD protein nlpD R4YHC8 40 kDa OM M 0.103661498 0.096204025 0.917190282 0.159794846
YfaZ protein yfaZ R4Y5J6 19 kDa OM S 0.005521834 0.000244548 0.963636031 0.002765098
LPS-assembly protein LptD lptD R4YBZ4 85 kDa OM M 0.01023447 0.471236646 0.883737772 0.491339369
FhuA protein fhuA R4Y5U8 81 kDa OM P 0.058798537 0.279868452 0.019594643 0.451572495
Scaffolding protein for murein-synthesising holoenzyme mipA G0GL03 28 kDa OM M 0.137502918 0.002618601 0.208084223 0.08573534
OmpW protein ompW R4YFW6 23 kDa OM M 0.708077095 0.258341975 0.652891377 0.456906134
Outer membrane protein assembly factor BamB yfgL G0GPX6 42 kDa OM S 0.192957266 0.607182655 0.73626647 0.814302958
ScrY protein scrY R4YDP8 56 kDa OM G 0.539203585 0.368647318 0.987037329 0.45539581
Putative outer membrane lipoprotein KPN2242_22575 G0GN82 22 kDa OM M 0.175531191 0.545685061 0.478859978 0.762660875
Outer membrane protein assembly factor BamC bamC R4Y768 37 kDa OM S 0.348473668 0.227055335 0.140293816 0.589196556
Penicillin-binding protein activator LpoA lpoA R4YEQ9 77 kDa OM M 0.052489047 0.174996986 0.355529362 0.4167415
OmpF protein ompK35 O87753 40 kDa OM M 0.533894249 0.172492227 0.40607487 0.313537249
Vitamin B12 transporter BtuB btuB R4Y432 68 kDa OM H 0.014701073 0.067343206 0.016853675 0.132027758
YbaY protein ybaY R4YCW8 15 kDa OM S 0.702471586 0.648718487 0.554843651 0.756316846
HemX protein hemX R4Y7E1 43 kDa OM H 0.48715791 0.528714103 0.886212464 0.304681689
ABC transporter outer membrane lipoprotein vacJ G0GNY0 28 kDa OM M 0.04065466 0.285973299 0.632111876 0.537148005
UTP--glucose-1-phosphate uridylyltransferase subunit GalU galU G0GHM2 33 kDa Cyt M 0.034347097 0.59485965 0.20551062 0.025855205
UDP-glucose pyrophosphorylase galF A2V7R3 33 kDa Cyt M 0.119816487 0.04695553 0.484091117 0.042847711
60 kDa chaperonin groEL groEL G0GGA7 57 kDa Cyt O 0.947970127 0.5770576 0.263385196 0.014366737
Chaperone protein DnaK dnaK R4Y5P6 68 kDa Cyt O 0.08979587 0.975414471 0.835305306 0.072418572
FKBP-type peptidyl-prolyl cis-trans isomeraseTrigger factor tig R4YHL8 48 kDa Cyt O 0.938021264 0.89919677 0.458743457 0.390130434
Heat shock protein 90 htpG G0GQB6 71 kDa Cyt O 0.078721774 0.87735271 0.798887446 0.155240973
ClpB protein clpB R4Y6I5 96 kDa Cyt O 0.943235249 0.009419364 0.875604728 0.043535515
Alkyl hydroperoxide reductase subunit C ahpC G0GT45 21 kDa Cyt O 0.030946765 0.278882194 0.326952871 0.762757251
Lon protease lon R4YEB6 89 kDa Cyt O 0.515628483 0.002942016 0.109416868 0.210164859
DegP protein degP R4Y5J4 50 kDa PP O 0.009792814 0.466458199 0.505534487 0.620710066
alkyl hydroperoxide reductase subunit C KPR_4367 R4YIQ4 22 kDa Cyt O 0.013423263 0.000127981 0.689981828 0.117892572
Co-chaperonin GroES groES1 G0GGA6 10 kDa Cyt O 0.09773809 0.371441019 0.246405738 0.373900966
peptidyl-prolyl cis-trans isomerase ybaU R4YHL6 68 kDa PP O 0.483881998 0.665568924 0.176606933 0.589196556
FtsH protease regulator HflK hflK G0GGE4 46 kDa IM O 0.804493398 0.208023667 0.912620939 0.223690157
Peptidyl-prolyl cis-trans isomerase KPR_0740 R4YBB0 23 kDa PP O 0.061446496 0.328361551 0.820425116 0.459798732
OM-OMVCOG Category
Supplemtal Table S2: P-values were assessed by single factor ANOVA to determine statistical significance for enrichment of outer membrane proteins and and chaperones between
Klebsiella pneumoniae ΔwbbO and 43816 outer membrane (OM) and outer membrane vesicle (OMV) samples.
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